Arthur L. Burnett, II, M. D., M.B.A. 

Patrick C. Walsh Distinguished Professor of Urology
Director, Basic Science Laboratory in Neurourology
Director, Sexual Medicine Fellowship Program
Faculty Member, Cellular and Molecular Medicine Graduate Training Program
Arthur L. Burnett, II, M. D., M.B.A.

Patrick C. Walsh Distinguished Professor of Urology,
Professor, Oncology Center
Director, Basic Science Laboratory in Neurourology
Director, Sexual Medicine Fellowship Program
Faculty Member, Cellular and Molecular Medicine Graduate Training Program

Johns Hopkins Medical Institutions

Address:
JHH-407 Marburg 21287

Appointments: 410-955-6100

Office: 410-614-3986

Email: aburnett@jhmi.edu

Fax: 410-614-3695
Erectile Dysfunction New Patient Information Form
Peyronies Disease New Patient Information Form

Arthur L. Burnett, II, MD is Professor, Department of Urology, at Johns Hopkins University School of Medicine, where he is also Director of the Basic Science Laboratory in Neuro-urology.  Currently, Dr. Burnett holds professional appointments at the Johns Hopkins Hospital including Director of the Male Consultation Clinic and clinician-scientist at the James Buchanan Brady Urological Institute.  Dr. Burnett received his undergraduate degree in biology from Princeton University and subsequently his medical degree at Johns Hopkins University School of Medicine.  He then completed his internship and residency in surgery, and subsequently residency and fellowship in urology at the Johns Hopkins Hospital.  Upon completion of his urology residency, he also received an American Foundation of Urologic Disease New Investigator Award to continue research work into the regulatory mechanisms of penile erection.  He has maintained an active laboratory in neuro-urology since that time.

Dr. Burnett is an established expert in the areas of:  prostate cancer; lower genitourinary tract malignancies (penile, scrotal, and urethral cancers); lower genitourinary tract reconstruction (pelvic trauma and urethral stricture disease); erectile dysfunction and penile abnormalities (including Peyronie's disease); and female urology (including urinary incontinence, urethral abnormalities, and prolapsed pelvic structures). This expertise is built on academic studies regarding the surgical anatomy of the pelvis, advances in surgical techniques of genital and pelvic reconstructive surgery, and basic science research contributions in the fundamental aspects of pelvic organ function.

His focus in the clinical practice of prostate cancer is reflected by his performance of over 2,000 radical prostatectomy surgeries, his application of a single, minimally invasive 3 inch incision just above the pubic bone which facilitates rapid recovery and cosmesis, his application of the "nerve-sparing" technique as described by Walsh, and his development of management approaches to improve postoperative functional outcomes following radical prostatectomy (see Erection Rehabilitation after Radical Prostatectomy).

Dr. Burnett is recognized for being a world-authority in the science and medicine of male erectile dysfunction.  He contributed original discoveries of the nitric oxide biochemical mechanisms in erectile tissue, that paved the way for the clinical development of oral medications to treat erectile dysfunction such as Viagra.  He has also pioneered work to develop therapies to protect penile nerve function required for improved erectile function recovery after radical prostatectomy.   

A frequent contributor to the medical press, Dr. Burnett has written more than 150 original peer-reviewed articles, along with numerous additional articles, editorials, and book chapters, relating to his biomedical research and clinical activities.   His work has appeared in many prominent journals such as Science, Nature Medicine, Proceedings of the National Academy of Sciences, Journal of Urology, Urology, and Journal of Andrology. A Fellow of the American College of Surgeons, Dr. Burnett is also a member of the American Urological Association, Sexual Medicine Society of North America, International Society for Sexual Medicine, Society of Genitourinary Reconstructive Surgeons, Society for Urodynamics and Female Urology, and the Society of Black Academic Surgeons.  He has sat on various advisory committees including the Urology Study Section, National Institutes of Health Center for Scientific Review and FDA Advisory Committee for Reproductive Health Drugs.


 EDUCATION

  • Undergraduate: A.B./1984. Princeton University Biology
  • Doctoral/graduate: M.D./1988. Johns Hopkins University Medicine

POST-DOCTORAL TRAINING

RESIDENCY TRAINING

  • Intern/1988-89 Johns Hopkins Hospital Surgery
  • Residency/1989-90 Johns Hopkins Hospital Surgery
  • Residency/1990-93 Johns Hopkins Hospital Urology
FELLOWSHIP TRAINING
  • Fellowship/1993-94 Johns Hopkins Hospital Urology
  • Fellowship/1994-96 Johns Hopkins Hospital Reconstructive Urology and Urodynamics

GRADUATE:

  • Certificate/2007-08 Johns Hopkins University Business of Medicine Carey Business School Graduate:
  • MBA/2009 Johns Hopkins University Medical Services Carey Business School Management

  1. 1990  Maryland State License
  2. 1998   Diplomate, American Board of Urology
  3. 2016   Recertification, American Board of Urology

Free Access to abstracts at PubMed

Publications:

Peer-reviewed scientific articles
  1. Takahashi, L.K.., Lisk, R.D., Burnett, A.L.II: "Dual Estradiol Action in Diencephalon and the Regulation of Socio-sexual Behavior in Female Golden Hamsters." Brain Res., 359 (1985),194-207.
  2. Berrettini, W.H., Bardakjian, J., Cappelari, C.B., Burnett, A.L.Jr., Albright, A.,Nurnberger, J.1., Gershon, E. S.: " Skin Fibroblast Beta-Adrenergic Receptor Function in Manic-Depressive Illness." Biol. Psychiatry, 22 (1987),1439-43.
  3. Burnett, A.L., Epstein, J.I., Marshall, F.F.: "Radical Cystectomy for Transitional Cell Carcinoma of the Bladder: Long Term Survival in High Risk Patients." Eur. Urol., 15 (1988), 171-5.
  4. Burnett, A.L., Epstein, J.I., Marshall, F.F.: "Adenocarcinoma of Urinary Bladder: Classification and Management." Urology, 37,4 (1991),315-21.
  5. Burnett, A.L., Lowenstein, C.J., Bredt, D.S., Chang, T.S.K., Snyder, S.H.: "Nitric Oxide: A Physiologic Mediator of Penile Erection." Science, 257 (1992), 401-3.
  6. Burnett, A.L., Chan, D.W., Brendler, C.B., Walsh, P.C.: "The Value of Enzymatic Acid Phosphatase in the Staging of Localized Prostate Cancer." J. Urol., 48 (1992), 1832-4.
  7. Burnett, A.L., Tillman, S.L., Chang, T.S.K., Epstein, J.I., Lowenstein, C.J., Bredt, D.S., Snyder, S.H., Walsh, P.C.: "Immunohistochemical Localization of Nitric Oxide Synthase in the Autonomic Innervation of the Human Penis. " J. Urol., 150 (1993), 73 -6.
  8. Burnett, A.L., Epstein, J.I., Gearhart, J.P.: "Spectrum of Differentiation in Pediatric Epithelial Tumors of Kidney: Report of Two Cases." Urology, 42,1 (1993), 93-8.
  9. Steiner, M.S., Burnett, A.L., Brooks, J.D., Brendler, C.B., Stutzman, R.E., Carter, H.B.: "Tubularized Neourethra Following Radical Retropubic Prostatectomy." J. Urol., 150(1993), 407-10.
  10. Burnett, A.L., Brendler, C.B.: "Femoral Neuropathy Following Major Pelvic Surgery: Etiology and Prevention." J. Urol., 151 (1994), 163 -5.
  11. Burnett, A.L., Ricker, D.D., Chamness, S.L., Maguire, M.P., Crone, J.K., Bredt, D.S., Snyder, S.H., Chang, T. S.K.: "Localization of Nitric Oxide Synthase in the Reproductive Organs of the Male Rat." Biol. Reprod., 52 (1995), 1-7.
  12. Burnett, A.L., Saito, S., Maguire, M.P., Yamaguchi, H., Chang, T.S.K., Hanley, D.F.: "Localization of Nitric Oxide Synthase in Spinal Nuclei Innervating Pelvic Ganglia." J. Urol., 153 (1995), 212-7.
  13. Gearhart, J.P., Burnett, A.L., Owen, J.H.: "Measurement of Pudendal Evoked Potentials During Feminizing Genitoplasty: Technique and Applications." J. Urol., 153 (1995), 486-7.
  14. Burnett, A.L.: "The Role of Nitric Oxide in the Physiology of Erection." Biol. Reprod., 52 (1995), 485-9.
  15. Burnett, A.L., Maguire, M.P., Chamness, S.L., Ricker, D.D., Takeda, M., Lepor, H., Chang, T. S.K.: "Characterization and Localization of Nitric Oxide Synthase in the Human Prostate." Urology, 45,3 (1995), 435-9.
  16. Takeda, M., Tang, R., Shapiro, E., Burnett, A.L., Lepor, H.: "Effects of Nitric Oxide on Human and Canine Prostates." Urology, 45,3 (1995), 440-6.
  17. Burnett, A.L., Allen, R.P., Tempany, C.M., Dover, G.J., Brendler, C.B.: "Evaluation of Erectile Function in Men with Sickle Cell Disease." Urology, 45,4 (1995), 657-63.
  18. Chamness, S.L., Ricker, D.D., Crone, J.K., Dembeck, C.L., Maguire, M.P., Burnett, A.L., Chang, T. S.K.: "The Effect of Androgen on Nitric Oxide Synthase in the Male Reproductive Tract of the Rat." 4 Fertil. Steril., 63,5 (1995), 1101-7.
  19. Burnett, A.L.: "Nitric Oxide Control of Lower Genitourinary Tract Functions: A Review." Urology, 45, 6 (1995),1071-83.
  20. Burnett, A.L., Nelson, R.J., Calvin, D.C., Liu, J., Demas, G.E., Klein, S.L., Kriegsfeld, L.J., Dawson, T.M., Snyder, S.H.: "Nitric Oxide Dependent Penile Erection in Mice Lacking Neuronal Nitric Oxide Synthase." Mol. Med., 2,3 (1996), 288-96.
  21. Burnett, A.L., Donowitz, M., Marshall, F.F.: "Inhibition of Transport Processes of lntestinal Segments Following Augmentation Enterocystoplasty in Rats." J. Urol., 156 (1996), 1872-5.
  22. Wesselmann, U., Burnett, A.L.: "Treatment of Neuropathic Testicular Pain." Neurology (Suppl.) (1996), 206.
  23. Burnett, A.L.: "Fascia Lata in Penile Reconstructive Surgery: A Reappraisal of the Fascia Lata Graft." Plas. Reconstr. Surg., 99,4 (1997), 1061-7.
  24. Burnett, A.L.: "Nitric Oxide in the Penis: Physiology and Pathology." J. Urol., 157 (1997), 320-4.
  25. Padma-Nathan, H., Hellstrom, W.J.G., Kaiser, F.E., et al, for the Medicated Urethral System for Erection (MUSE) Study Group.: "Treatment of Men with Erectile Dysfunction with Transurethral Alprostadil." N. Engl. J. Med., 336 (1997), 1-7.
  26. Han, M., Burnett, A.L., Fishman, E.K., Marshall, F.F.: "The Natural History and Treatment of Adrenal Myelolipoma." J. Urol., 157 (1997), 1213-6.
  27. Burnett, A.L., Calvin, D.C., Chamness, S.L., Liu, J.-X., Dawson, V.L., Dawson, T.M., Snyder, S.H.: "Urinary Bladder-Urethral Sphincter Dysfunction in Mice with Targeted Disruption of Neuronal Nitric Oxide Synthase Models Idiopathic Voiding Disorders in Humans." Nature Med., 3 (1997), 571-4.
  28. Burnett, A.L., Calvin, D.C., Silver, R.I., Peppas, D.S., Docimo, S.G.: "Immunohistochemical Description of Nitric Oxide Synthase Isoforms in Human Clitoris." J. Urol., 158 (1997), 75-8.
  29. Wesselmann, U., Burnett, A.L., Heinberg, L.J.: "The Urogenital and Rectal Pain Syndromes." Pain 73 (1997), 269-94.
  30. Burnett, A.L., Johns, D.G., Kriegsfeld, L.J., Klein, S.L., Calvin, D.C., Demas, G.E., Schramm, L.P., Tonegawa, S., Nelson, R.J.,, Snyder, S.H., Poss, K.D.: "Ejaculatory Abnormalities in Mice with Targeted Disruption of Heme Oxygenase-2." Nature Med. 4 (1998), 84-7.
  31. Burnett, A.L.: "Erectile Dysfunction: A Practical Approach For Primary Care." Geriatrics 53 (1998), 34-48.
  32. Crone, J.K., Burnett, A.L., Chamness, S.L., Strandberg, J.D., Chang, T. S.: "Neuronal Nitric Oxide Synthase in the Canine Prostate: Aging, Sex Steroid and Pathology Correlations." J. Androl. 19 (1998), 358-64.
  33. Burnett, A.L., Mostwin, J.L.: "In Situ Anatomical Study of the Male Urethral Sphincteric Complex: Relevance to Urinary Continence Preservation Following Major Pelvic Surgery." J. Urol. 160 (1998), 1301-6.
  34. Klein, S.L., Carnovale, D., Burnett, A.L., Wallach, E.E., Zacur, H.A., Dawson, V.L., Nelson, R.J., Dawson, T.M.: "Impaired Ovulation in Mice with Targeted Deletion of the Neuronal Isoform of Nitric Oxide Synthase." Mol. Med. 4 (1998), 658-64.
  35. Althof, S.E., Corty, E.W., Levine, S.B., Seftel, A., Levine, F., Burnett, A.L., McVary, K., Stecher, V.: "The EDITS: The Development of Questionnaires for Evaluating Satisfaction with Treatments for Erectile Dysfunction." Urology 53 (1999), 793-9.
  36. Burnett, A.L., Wesselmann, U.: "History of the Neurobiology of the Pelvis." Urology 53 (1999), 1082-9.
  37. Burnett, A.L., Wesselmann, U.: "Neurobiology of the Pelvis and Perineum: Principles for a Practical Approach." J. Pelvic Surgery 5 (1999), 224-32.
  38. Jarow, J.P., Burnett, A.L., Geringer, A.M.: "Clinical Efficacy of Sildenafil Citrate Based upon Etiology and Response to Prior Treatment." J. Urol. 162 (1999), 722-5.
  39. Drazen, D.L., Klein, S.L., Burnett, A.L., Wallach, E.E., Crone, J.K., Huang, P.L., Nelson, R.J.: "Reproductive Function in Female Mice Lacking the Gene for Endothelial Nitric Oxide Synthase." Nitric Oxide: Biol. Chem. 3, 5 (1999), 366-74.
  40. Kriegsfeld, L.J., Demas, GE., Burnett, A.L., Nelson, R.J.: "Ejaculatory Abnormalities in Mice Lacking the Gene for Endothelial Nitric Oxide Synthase (eNOS-/-)." Physiol. Behav. 67 (1999), 561-6.
  41. Burnett, A.L.: "Oral Pharmacotherapy for Erectile Dysfunction: Current Perspectives." Urology 54 (1999), 561-6.
  42. Sezen, S. F., Burnett, A.L.: "Intracavernosal Pressure Monitoring in Mice: Responses to Electrical Stimulation of the Cavernous Nerve and to Intracavernosal Drug Administration." J. Androl. 21 (2000), 311-5.
  43. Basson, R., Berman, J., Burnett, A., et al.: "Report of the International Consensus Development Conference on Female Sexual Dysfunction: Definitions and Classifications." J. Urol. 163 (2000), 888-93.
  44. Rowland, D.L., Burnett, A.L.: "Pharmacotherapy in the Treatment of Male Sexual Dysfunction." J. Sex Research 37 (2000), 226-43.
  45. Walsh, P.C., Marschke, P., Ricker, D., Burnett, A.L.: "Patient-Reported Urinary Continence and Sexual Function Following Anatomic Radical Prostatectomy." Urology 55 (2000), 58-61.
  46. Walsh, P.C., Marschke, P., Ricker, D., Burnett, A.L.: "Use of Intraoperative Video Documentation to Improve Sexual Function Following Radical Retropubic Prostatectomy." Urology 55 (2000), 62-7.
  47. Gonzalez-Cadavid, N.F., Burnett, A.L., Magee, T.R., Zeller, C.B., Vernet, D., Smith, N., Gitter, J., Rajfer, J.: "Expression of Penile Neuronal Nitric Oxide Synthase Variants in the Rat and Mouse Penile Nerves." Biol. Reprod. 63 (2000), 704-14.
  48. Burnett, A.L., Allen, R.P., Davis, D.M. Wright, D.C., Trueheart, I.N., Chance, B.: "Near Infrared Spectrophotometry for the Diagnosis of Vasculogenic Erectile Dysfunction." Int. J. Impotence Res. 12 (2000), 247-54.
  49. Burnett, A.L.: "Novel Pharmacological Approaches in the Treatment of Erectile Dysfunction." World J. Urol. 19 (2001), 57-66.
  50. Meldrum, K.K., Meldrum, D.R., Sezen, S.F., Crone, J.K., Burnett, A.L.: "Heat Shock Prevents Simulated Ischemia-Induced Apoptosis in Renal Tubular Cells Via a PKC-dependent Mechanism." Am. J. Physiol. Regul. Integr. Comp. Physiol. 281 (2001), R359-64.
  51. Meldrum, K.K., Meldrum, D.R., Hile, K.L, Burnett, A.L., Harken, A.H.: "A Novel Model of Ischemia in Renal Tubular Cells Which Closely Parallels in Vivo Injury." J. Surg. Res. 99 (2001), 288-293.
  52. Sezen, S.F., Hoke, A., Burnett, A.L., Snyder, S.H.: "Immunophilin Ligand FK506 is Neuroprotective for Penile Innervation." Nature Med. 7 (2001), 1073-4.
  53. Palese, M.A., Burnett, A.L.: "Corporoplasty Using Pericardium Allograft (Tutoplast) with Complex Penile Prosthesis Surgery." Urology 58 (2001), 1049-52.
  54. Akingba, A.G., Burnett, A.L.: "Endothelial Nitric Oxide Synthase Protein Expression, Localization, and Activity in the Penis of the Alloxan-Induced Diabetic Rat." Mol. Urol. 5 (2001), 189-97.
  55. Burnett, A.L., Chang, A.G., Crone, J.K., Huang, P.L., Sezen, S.F.: "Non-Cholinergic Penile Erection in Mice Lacking the Gene for Endothelial Nitric Oxide Synthase." J. Androl. 23 (2002), 92-7.
  56. Hurt, K.J, Musicki, B., Palese, M.A., Crone, J.K., Becker, R.E., Moriarity, J.L., Snyder, S.H., Burnett, A.L.: "Akt-Dependent Phosphorylation of Endothelial Nitric Oxide Synthase Mediates Penile Erection." Proc. Natl. Acad. Sci. 99 (2002), 4061-6.
  57. Barouch, L.A., Harrison, R.W., Skaf, M.M., Rosas, G.O., Cappola, T.P., Kobeissi, Z.A., Hobai, I.A., Lemmon, C.A., Burnett, A.L., O‟Rourke, B., Rodriguez, E.R., Huang, P.L., Lima, J.A.C., Berkowitz, D.E., Hare, J.M.: "Nitric Oxide Regulates the Heart by Spatial Confinement of Nitric Oxide Synthase Isoforms." Nature 416 (2002), 337-9.
  58. Meldrum, K.K., Hile, K., Meldrum, D.R., Crone, J.A., Gearhart, J.P., Burnett, A.L.: "Simulated Ischemia Induces Renal Tubular Cell Apoptosis Through a Nuclear Factor-KappaB Dependent Mechanism." J. Urol. 168 (2002), 248-52.
  59. Carson, C.C., Burnett, A.L., Levine, L.A., Nehra, A.: "The Efficacy of Sildenafil Citrate in Clinical Populations." Urology 60 (2002), 12-27.
  60. Burnett, A.L.: "Nitric Oxide Regulation of Penile Erection: Biology and Therapeutic Implications." J. Androl. 23 (2002), S20-S26.
  61. Burnett, A.L., Truss, M.C.: "Mediators of the Female Sexual Response: Pharmacotherapeutic Implications." World J. Urol. 20 (2002), 101-105.
  62. Zhou, L., Burnett, A.L., Huang, P.L., Becker, L.C., Kuppusamy, P., Kass, D.A., Donahue, J.K., Proud, D., Sham, J.S.K., Dawson, T.M., Xu, K.Y.: "Lack of Nitric Oxide Synthase Depresses Ion Transporting Enzyme Function in Cardiac Muscle." Biochem. Biophys. Res. Commun. 294 (2002), 1030-35.
  63. Derogatis, L.R., Rosen, R., Leiblum, S., Burnett, A.L., Heiman, J.: "The Female Sexual Distress Scale (FSDS): Initial Validation of a Standardized Scale for Assessment of Sexually Related Personal Distress in Women." J. Sex. Marital. Ther. 28 (2002), 317-30.
  64. Sezen, S.F., Blackshaw, S., Steiner, J.P., Burnett, A.L.: "FK506 Binding Protein 12 is Expressed in Rat Penile Innervation and Upregulated after Cavernous Nerve Injury." Int. J. Impotence Res. 14 (2002), 506-12.
  65. Magee, T.R., Zeller, C.B., Ferrini, M.G., Davila, H., Vernet, D., Sun, J., Burnett, A.L., Lalani, R., Rajfer, J., Gonzalez-Cadavid, N.F.: "The Protein Inhibitor of NOS (PIN) and the NMDA Receptor are Expressed in the Rat and Mouse Penile Nerves and Co-localize with Penile Neuronal NOS (PnNOS)." Biol. Reprod. 68 (2003), 478-88.
  66. Meldrum, K.K., Burnett, A.L., Meng, X., Misseri, R., Shaw, M.B.K., Gearhart, J.P., Meldrum, D.R.: "Liposomal Delivery of Heat Shock Protein 72 into Renal Tubular Cells Blocks Nuclear Factor-Kappa B Activation, Tumor Factor Necrosis-Alpha Production, and Subsequent Ischemia-Induced Apoptosis." Circ. Res. 92 (2003), 294-299.
  67. Burnett, A.L.: "Rationale for Cavernous Nerve Restorative Therapies to Preserve Erectile Function after Radical Prostatectomy." Urology 61 (2003), 491-497.
  68. Burnett, A.L.: "Pathophysiology of Priapism: Dysregulatory Erection Physiology Thesis." J. Urol. 170 (2003), 26-34.
  69. Burnett, A.L.: "Neuroprotection and Nerve Grafts in the Treatment of Neurogenic Erectile Dysfunction." J. Urol. 170 (2003), S31-S34.
  70. Burnett, A. L.: "Strategies to Promote Recovery of Cavernous Nerve Function after Radical Prostatectomy." World J. Urol. 20 (2003), 337-342.
  71. Barouch, L.A., Cappola, T.P., Harrison, R.W., Crone, J.K., Rodriguez, E.R., Burnett, A.L., Hare,J.M.: "Combined Loss of Neuronal and Endothelial Nitric Oxide Synthase Causes Premature Mortality and Age-Related Hypertrophic Cardiac Remodeling in Mice." J. Mol. Cell. Cardiol. 35 (2003), 637-644.
  72. Gonzalgo, M.L., Brotzman, M., Trock, B.J., Geringer, A.M., Burnett, A.L., Jarow, J.P.: "Clinical Efficacy of Sildenafil Citrate and Predictors of Long-term Response." J.Urol. 170 (2003), 503-506.
  73. Palese, M.A., Crone, J.K., Burnett, A.L.: "A Castrated Mouse Model of Erectile Dysfunction." J. Androl. 24 (2003), 699-703.
  74. Burnett, A.L.: "Priapism Pathophysiology: Clues to Prevention." Int. J. Impot. Res. 15 Suppl 5 (2003), S80-S85.
  75. Burnett, A.L.: "Neurophysiology of Erectile Function: Androgenic Effects." J. Androl. 24 (2003), S2-S5.
  76. Xu, K.Y., Kuppusamy, S.P., Wang, J.Q., Li, H., Cui, H., Dawson, T.M., Huang, P.L., Burnett, A.L., Kuppusamy, P., Becker, L.C.: "Nitric Oxide Protects Cardiac Sarcolemmal Membrane Enzyme Function and Ion Active Transport against Ischemia-induced Inactivation." J. Biol. Chem. 278 (2003), 41798-41803.
  77. Burnett, A.L., Becker, R.E.: "Immunophilin Ligands Promote Penile Neurogenesis and Erection Recovery after Cavernous Nerve Injury." J. Urol. 171 (2004), 495-500.
  78. Musicki, B., Palese, M.A., Crone, J.K., Burnett, A.L.: "Phosphorylated Endothelial Nitric Oxide Synthase Mediates Vascular Endothelial Growth Factor-Induced Penile Erection." Biol. Reprod. 70 (2004), 282-289.
  79. Montorsi, F., Briganti, A., Salonia, A., Rigatti, P., Burnett, A.L.: "Current and Future Strategies for Preventing and Managing Erectile Dysfunction following Radical Prostatectomy." Eur. Urol. 45 (2004), 123-133.
  80. Burnett, A.L.: "The Impact of Sildenafil on Molecular Science and Sexual Health." Eur. Urol. 46(2004), 9-14.
  81. Burnett, A.L.: "Novel Nitric Oxide Signaling Mechanisms Regulate the Erectile Response." Int. J. Impot. Res. 16 (2004), S15-S19.
  82. Champion, H.C., Bivalacqua, T.J., Takimoto, E., Kass, D.A., Burnett, A.L.: "Phosphodiesterase-5A Dysregulation in Penile Erectile Tissue is a Mechanism of Priapism." Proc. Natl. Acad. Sci. 102 (2005), 1661-1666.
  83. Burnett, A.L.: "Vasoactive Pharmacotherapy to Cure Erectile Dysfunction: Fact or Fiction?" Urology 65 (2005), 224-230.
  84. Rowland, D.L., Thornton, J.A., Burnett, A.L.: "Recognizing the Risk of Erectile Dysfunction in a Urology Clinic Practice." BJU Int. 95 (2005), 1034-1038.
  85. Musicki, B., Kramer, M.F., Becker, R.E., Burnett, A.L.: "Age-Related Changes in Phosphorylation of Endothelial Nitric Oxide Synthase in the Rat Penis." J. Sex. Med. 2 (2005), 347-357.
  86. Burnett, A.L., Kramer, M.F., Dalrymple, S., Isaacs, J.T.: "Nonimmunosuppressant Immunophilin Ligand GPI-1046 Does Not Promote in Vitro Growth of Prostate Cancer Cells." Urology. 65 (2005), 1003-1007.
  87. Burnett, A.L.: "Erectile Dysfunction Following Radical Prostatectomy." JAMA. 293 (2005), 2648-2653.
  88. Musicki, B., Champion, H.C., Becker, R.E., Liu, T., Kramer, M.F., Burnett, A.L.: "Erection Capability is Potentiated by Long-Term Sildenafil Treatment: Role of Blood Flow-Induced Endothelial Nitric Oxide Synthase Phosphorylation." Mol. Pharmacol. 68 (2005), 226-232.
  89. Kostis, J.B, Jackson, G., Rosen, R., Barrett-Connor, E., Billups, K., Burnett, A.L., et al: "Sexual Dysfunction and Cardiac Risk (the Second Princeton Consensus Conference)." Am. J. Cardiol. 96 (2005), 313-321.
  90. Burnett, A.L.: "Nitric Oxide-Based Therapy for Erectile Disorders." Drug Discovery Today: Therapeutic Strategies 2 (2005), 25-30.
  91. Musicki, B., Kramer, M.F., Becker, R.E., Burnett, A.L.: "Inactivation of Phosphorylated Endothelial Nitric Oxide Synthase (Ser-1177) by O-GlcNAc in Diabetes-Associated Erectile Dysfunction." Proc. Natl. Acad. Sci. 102 (2005), 11870-11875.
  92. Musicki, B., Champion, H.C., Becker, R.E., Kramer, M.F., Liu, T., Sezen, S.F., Burnett, A.L.: "In Vivo Analysis of Chronic Phosphodiesterase-5 Inhibition with Sildenafil in Penile Erectile Tissues: No Tachyphylaxis Effect." J. Urol. 174 (2005), 1493-1496.
  93. Shabsigh, R., Burnett, A.L., Eardley, I., Sharlip, I.D., Ellsworth, P.I., Garcia, C.S., Natanegara, F., Ahuja, S.: "Time from Dosing to Sexual Intercourse Attempts in Men Taking Tadalafil in Clinical Trials." B.J.U. Int. 96 (2005), 857-863.
  94. Burnett, A.L.: "Therapy Insight: Priapism associated with Hematologic Dyscrasias." Nature Clin. Pract. Urol. 2 (2005), 449-456.
  95. Allaf, M.E., Hoke, A., Burnett, A.L.: "Erythropoietin Promotes the Recovery of Erectile Function following Cavernous Nerve Injury." J. Urol. 174 (2005), 2060-2064.
  96. Burnett, A.L.: "Metabolic Syndrome, Endothelial Dysfunction, and Erectile Dysfunction: Association and Management." Curr. Urol. Rep. (2005), 470-475.
  97. Burnett, A.L., Musicki, B.: "The Nitric Oxide Signaling Pathway in the Penis." Curr. Pharm. Des. 11 (2005), 3987-3994.
  98. Bivalacqua, T.J., Musicki, B., Usta, M.F., Champion, H.C., Kadowitz, P.J., Burnett, A.L., Hellstrom, W.J.G.: "Endothelial Nitric Oxide Synthase Gene Therapy for Erectile Dysfunction." Curr. Pharm. Des. 11 (2005), 4059-4068.
  99. Burnett, A.L.: "Phosphodiesterase 5 Mechanisms and Therapeutic Applications." Am. J. Cardiol. 96 (2005), 29-31.
  100. Burnett, A.L.: "Neuromodulatory Therapy with Applications for the Radical Pelvic Surgery Patient." Current Sexual Health Reports 2 (2005), 69-73.
  101. Jin, L., Liu, T., Lagoda, G.A., Champion, H.C., Bivalacqua, T.J., Burnett, A.L.: "Elevated RhoA/Rho-kinase Activity in the Aged Rat Penis: Mechanism for Age-Associated Erectile Dysfunction." FASEB J. 20 (2006), 536-538.
  102. Jin, L., Burnett, A.L.: "RhoA/Rho-kinase in Erectile Tissue: Mechanisms of Disease and Therapeutic Insights." Clin. Sci. 110 (2006), 153-165.
  103. Montorsi, F., Briganti, A., Salonia, A., Rigatti, P., Burnett, A.L.: "Can Phosphodiesterase Type 5 Inhibitors Cure Erectile Dysfunction?" Eur. Urol. 49 (2006), 979-986.
  104. Musicki, B., Burnett, A.L.: "eNOS Function and Dysfunction in the Penis." Exp. Biol. Med. 231 (2006), 154-165.
  105. Blaivas, J.G., Burnett, A.L., Wein, A.J.: "Current Trends in Lower Urinary Tract Health Highlights from Annual Advances in Genitourinary Health: A Scientific Update." J. Urol. 175 (2006), S3-S4.
  106. Burnett, A.L., Wein, A.J.: "Benign Prostatic Hyperplasia in Primary Care: What You Need to Know." J. Urol. 175 (2006), S19-S24.
  107. Burnett, A.L.: "Erectile Dysfunction." J. Urol. 175 (2006), S25-S31.
  108. Hurt, K.J., Sezen, S.F., Champion, H.C., Crone, J.K., Palese, M.A., Huang, P.L., Sawa, A., Luo, X., Musicki, B., Snyder, S.H., Burnett, A.L.: "Alternatively Spliced Neuronal Nitric Oxide Synthase Mediates Penile Erection." Proc. Natl. Acad. Sci. 103 (2006), 3440-3443.
  109. Burnett, A.L., Musicki, B., Jin, L., Bivalacqua, T.J.: "Nitric Oxide/Redox-Based Signalling as a Therapeutic Target for Penile Disorders." Expert Opin. Ther. Targets 10 (2006), 445-457.
  110. Burnett, A.L., Bivalacqua, T.J., Champion, H.C., Musicki, B.: "Long-Term Oral Phosphodiesterase 5 Inhibitor Therapy Alleviates Recurrent Priapism." Urology 67 (2006), 1043-1048.
  111. Musicki, B., Burnett, A.L.: "Endothelial Dysfunction in Diabetic Erectile Dysfunction." Int. J. Impot. Res. 19 (2006), 129-138.
  112. Burnett, A.L.: "Nitric Oxide in the Penis-Science and Therapeutic Implications from Erectile Dysfunction to Priapism." J. Sex. Med. 3 (2006), 578-582.
  113. Burnett, A.L., Lue, T.: "Neuromodulatory Therapy to Improve Erectile Function Recovery Outcomes after Pelvic Surgery." J. Urol. 176 (2006), 882-887.
  114. Bivalacqua, T.J., Burnett, A.L.: "Priapism: New Concepts in the Pathophysiology and New Treatment Strategies." Curr. Urol. Rep. 7 (2006), 497-502.
  115. Bivalacqua, T.J., Burnett, A.L., Hellstrom, W., Champion, H.C.: "Overexpression of Arginase in the Aged Mouse Penis Impairs Erectile Function and Decreases NOS3 Activity: Influence of In Vivo Gene Therapy of Anti-Arginase." Am. J. Physiol. Heart Circ. Physiol. 292 (2006), H1340-H1351.
  116. Rosen, R.C., Catania, J.A., Ehrhardt, A.A., Burnett, A.L., Lue, T.F., McKenna, K., et al.: "The Bolger Conference on PDE-5 Inhibition and HIV Risk: Implications for Health Policy and Prevention." J. Sex. Med. 36 (2006), 960-975.
  117. Burnett, A.L., Bivalacqua, T.J., Champion, H.C., Musicki, B.: "Feasibility of the Use of Phosphodiesterase Type 5 Inhibitors in a Pharmacologic Prevention Program for Recurrent Priapism." J. Sex. Med. 3 (2006), 1077-1084.
  118. Burnett, A.L.: "The Role of Nitric Oxide in Erectile Dysfunction: Implications for Medical Therapy." J. Clin. Hypertens. 8 (2006), 53-62.
  119. Bivalacqua, T.J., Liu, T., Musicki, B., Champion, H.C., Burnett, A.L.: "Endothelial Nitric Oxide Synthase Keeps Erection Regulatory Function Balance in the Penis." Eur. Urol. 51 (2007), 1732-1740.
  120. Valentine, H., Chen, Y., Guo, H., McCormick, J., Wu, Y., Sezen, S.F., Hoke, A., Burnett, A.L., Steiner, J.P.: "Neuroimmunophilin Ligands Protect Cavernous Nerves after Crush Injury in the Rat: New Experimental Paradigms." Eur. Urol. 51 (2007), 1724-1731.
  121. Fried, N.M., Rais-Bahrami, S., Lagoda, G.A., Chung, Y., Burnett, A.L., Su, L.M.: "Imaging the Cavernous Nerves in the Rat Prostate Using Optical Coherence Tomography." Lasers. Surg. Med. 39 (2007), 36-41.
  122. Cookson, M.S., Aus, G., Burnett, A.L., Canby-Hagino, E.D., D‟Amico, A.V., Dmochowski, R.R., Eton, D.T., Forman, J.D., Goldenberg, S.L., Hernandez, J., Higano, C.S., Kraus, S.R., Moul, J.W., Tangen, C., Thrasher, J.B., Thompson, I.: "Variation in the Definition of Biochemical Recurrence in Patients Treated for Localized Prostate Cancer: The American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel Report and Recommendations for a Standard in the Reporting of Surgical Outcomes." J. Urol. 177 (2007), 540-545.
  123. Selvin, E., Burnett, A.L., Platz, E.A.: "Prevalence and Risk Factors for Erectile Dysfunction in the US." Am. J. Med. 120 (2007), 151-157.
  124. Burnett, A.L., Musicki, B., Bivalacqua, T.J.: "Molecular Science of Priapism." Curr. Sex. Health Rep. 4 (2007), 9-14.
  125. Derogatis, L.R., Burnett, A.L.: "Key Methodological Issues in Sexual Medicine Research (CME)." J. Sex. Med. 4 (2007), 527-537.
  126. Thompson, I., Thrasher, J.B., Aus, G., Burnett, A.L., Canby-Hagino, E.D., Cookson, M.S., D‟Amico, A.V., Dmochowski, R.R., Eton, D.T., Forman, J.D., Goldenberg, S.L., Hernandez, J., Higano, C.S., Kraus, S.R., Moul, J.W., Tangen, C.M.; Prostate Cancer Clinical Guideline Update Panel: "Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update." J. Urol. 177 (2007), 2106-2131.
  127. Burnett, A.L., Aus, G., Canby-Hagino, E.D., Cookson, M.S., D‟Amico, A.V., Dmochowski, R.R., Eton, D.T., Forman, J.D., Goldenberg, S.L., Hernanadez, J., Higano, C.S., Kraus, S., Liebert, M., Moul, J.W., Tangen, C., Thrasher, J.B., Thompson, I.; American Urological Association Prostate Cancer Guideline Update Panel: "Erectile Function Outcome Reporting after Clinically Localized Prostate Cancer Treatment." J. Urol. 178 (2007), 597-601.
  128. Lagoda, G., Jin, L., Lehrfeld, T.J., Liu, T., Burnett, A.L.: "FK506 and Sildenafil Promote Erectile Function Recovery after Cavernous Nerve Injury through Antioxidative Mechanisms." J. Sex. Med. 4 (2007), 908-916.
  129. Liu, T., Allaf, M.E., Lagoda, G., Burnett, A.L.: "Erythropoietin Receptor Expression in the Human Urogenital Tract: Immunolocalization in the Prostate, Neurovascular Bundle and Penis." BJU. Int. 100 (2007), 1103-1106.
  130. Burnett, A.L.: "Molecular Pharmacotherapeutic Targeting of PDE5 for Preservation of Penile Health." J. Androl. 29 (2007), 3-14 .
  131. Glina, S., Burnett, A.L., Becher, E., Brock, G., Hellstrom, W.: "Priapism: Reasons for Failure by Frank Hinman, Jr.." J. Sex. Med. 4 (2007), 1539-1543.
  132. Burnett, A.L., Bivalacqua, T.J.: "Glucose-6-Phosphate Dehydrogenase Deficiency: An Etiology for Idiopathic Priapism?" J. Sex. Med. 5 (2007), 237-240.
  133. Burnett, A.L., Bivalacqua, T.J.: "Priapism: Current Principles and Practice." Urol. Clin. North Am. 34 (2007), 631-642.
  134. Lagoda, G., Sezen, S.F., Liu, T., Höke, A., Burnett, A.L.: "FK506-Binding Protein Localizations in Human Penile Innervation." BJU Int. 101 (2007), 604-609.
  135. Derogatis, L.R., Burnett, A.L.: "The Epidemiology of Sexual Dysfunctions." J. Sex. Med. 5 (2007), 289-300.
  136. Fried, N.M., Rais-Bahrami, S., Lagoda, G.A., Chuang, Y., Su, L.M., Burnett, A.L.: "Identification and Imaging of the Nerves Responsible for Erectile Function in Rat Prostate, In Vivo, using Optical Nerve Stimulation and Optical Coherence Tomography." IEEE Trans. Biomed. Eng. 13 (2007), 1641-1645.
  137. Jin, L., Burnett, A.L.: "NADPH Oxidase: Recent Evidence for its Role in Erectile Dysfunction." Asian J. Androl. 10 (2008), 6-13.
  138. Strong, T.D., Gebska, M.A., Burnett, A.L., Champion, H.C., Bivalacqua, T.J.: "Endothelium-Specific Gene and Stem Cell-based Therapy for Erectile Dysfunction." Asian J. Androl. 10 (2008), 14-22.
  139. Musicki, B., Liu, T., Strong, T., Jin, L., Laughlin, M.H., Turk, J.R., Burnett, A.L.: "Low-Fat Diet and Exercise Preserve eNOS Regulation and Endothelial Function in the Penis of Early Atherosclerotic Pigs: A Molecular Analysis." J. Sex. Med. 5 (2008), 552-561.
  140. Strong, T.D., Gebska, M.A., Champion, H.C., Burnett, A.L., Bivalacqua, T.J.: "Stem and Endothelial Progenitor Cells in Erection Biology." Int. J. Impot. Res. 120 (2008), 243-254.
  141. Fried, N.M., Lagoda, G.A., Scott, N.J., Su, L.M., Burnett, A.L.: "Noncontact Stimulation of the Cavernous Nerves in the Rat Prostate using a Tunable-Wavelength Thulium Fiber Laser." J. Endourol. 22 (2008), 409-413.
  142. Rais-Bahrami, S., Levinson, A.W., Fried, N.M., Lagoda, G.A., Hristov, A., Chuang,Y., Burnett, A.L., Su, L.M.: "Optical Coherence Tomography of Cavernous Nerves: A Step Toward Real-time Intraoperative Imaging During Nerve-Sparing Radical Prostatectomy." Urology. 72 (2008),198-204.
  143. Jin, L., Lagoda, G., Leite, R., Webb, R.C., Burnett, A.L.: "NADPH Oxidase Activation: A Mechanism of Hypertension-Associated Erectile Dysfunction." J. Sex. Med. 5 (2008), 544-551.
  144. Burnett, A.L.: "Environmental Erectile Dysfunction: Can the Environment Really Be Hazardous to Your Erectile Health?" J. Androl. 29 (2008), 229-236.
  145. Canguven O, Burnett, A.L.: "The Effect of 5 Alpha-Reductase Inhibitors on Erectile Function." J. Androl. 29 (2008), 514-523.
  146. Burnett, A.L., Teloken, P.E., Briganti, A., Whitehurst, T., Montorsi, F.: "Intraoperative Assessment of an Implantable Electrode Array for Cavernous Nerve Stimulation." J. Sex. Med. 5 (2008), 1949-1954.
  147. Bivalacqua, T.J., Guzzo, T.J., Schaeffer, E.M., Gebska, M.A., Champion, H.C., Burnett, A.L., Gonzalgo, M.L.: "Application of Evicel to Cavernous Nerves of the Rat Does Not Influence Erectile Function in Vivo." Urology 72 (2008), 1169-1173.
  148. Burnett, A.L., Allaf, M.E., Bivalacqua, T.J.: "Erythropoietin Promotes Erection Recovery after Nerve-Sparing Radical Prostatectomy: A Retrospective Analysis." J. Sex. Med. 5 (2008), 2392-2398.
  149. Fried, N.M., Lagoda, G.A., Scott, N.J., Su, L.M., Burnett, A.L.: "Laser Stimulation of the Cavernous Nerves in the Rat Prostate, In Vivo: Optimization of Wavelength, Pulse Energy, and Pulse Repetition Rate." Conf. Proc. IEEE Eng. Med. Biol. Soc. 1 (2008), 2777-2780.
  150. Burnett, A.L.: "Erectile Dysfunction Management for the Future." J. Androl. 30 (2009), 391-396.
  151. Hatzimouratidis, K., Burnett, A.L., Hatzichristou, D., McCullough, A.R., Montorsi, F., Mulhall, J.P.: "Phosphodiesterase Type 5 Inhibitors in Postprostatectomy Erectile Dysfunction: A Critical Analysis of the Basic Science Rationale and Clinical Application." Eur. Urol. 55 (2009), 334-347.
  152. Burnett, A.L., Strong, T.D., Trock, B.J., Jin, L., Bivalacqua, T.J., Musicki, B.: "Serum Biomarker Measurements of Endothelial Function and Oxidative Stress after Daily Dosing of Sildenafil in Type 2 Diabetic Men with Erectile Dysfunction." J. Urol. 181 (2009), 245-251.
  153. Bivalacqua, T.J., Sussan, T.E., Gebska, M.A., Strong, T.D., Berkowitz, D.E., Biswal, S., Burnett, A.L., Champion, H.C.: "Sildenafil Inhibits Superoxide Formation and Prevents Endothelial Dysfunction in a Mouse Model of Secondhand Smoke Induced Erectile Dysfunction." J. Urol. 181 (2009), 899-906.
  154. Burnett, A.L., Santiago, C.S. 3rd.: "Resolution of Recurrent Ischemic Priapism after Celiac Plexus Block: Case Report Evidence for its Neurogenic Origin?" J. Sex. Med. 6 (2009), 886-889.
  155. Burnett, A.L., Pierorazio, P.M.: "Corporal "Snake" Maneuver: Corporoglanular Shunt Surgical Modification for Ischemic Priapism." J. Sex. Med. 6 (2009), 1171-1176.
  156. Musicki, B., Liu, T., Lagoda, G.A., Bivalacqua, T.J., Strong, T.D., Burnett, A.L.: "Endothelial Nitric Oxide Synthase Regulation in Female Genital Tract Structures." J. Sex. Med. 6 Suppl 3 (2009), 247-253.
  157. Sezen, S.F., Lagoda, G., Burnett, A.L.: "Role of Immunophilins in Recovery of Erectile Function after Cavernous Nerve Injury." J. Sex. Med. 6 Suppl 3 (2009), 340-346.
  158. Musicki, B., Ross, A.E., Champion, H.C., Burnett, A.L., Bivalacqua, T.J.: "Post-Translational Modification of Constitutive Nitric Oxide Synthase in the Penis." J. Androl. 30 (2009), 352-362.
  159. Canguven, O., Lagoda, G., Sezen, S.F., Burnett, A.L.: "Losartan Preserves Erectile Function After Bilateral Cavernous Nerve Injury via Antifibrotic Mechanisms in Male Rats." J. Urol. 181 (2009), 2816-2822.
  160. Lagoda, G., Sezen, S.F., Burnett, A.L.: "FK506 and Rapamycin Neuroprotect Erection and Involve Different Immunophilins in a Rat Model of Cavernous Nerve Injury." J. Sex. Med. 6 (2009), 1914-1923.
  161. Burnett, A.L.: "Anxiety Disorders in Patients with Idiopathic Priapism: Risk Factor and Pathophysiologic Link?" J. Sex. Med. 6 (2009), 1712-1718.
  162. Bivalacqua, T.J., Musicki, B., Hsu, L.L., Gladwin, M.T., Burnett, A.L., Champion, H.C.: "Establishment of a Transgenic Sickle-Cell Mouse Model to Study the Pathophysiology of Priapism." J. Sex. Med. 6 (2009), 2494-2504.
  163. Facio, F., Jr., Burnett, A.L.: "Penile Rehabilitation and Neuromodulation." Scientific World Journal 9 (2009), 652-664.
  164. Canguven, O., Bailen, J., Fredriksson, W., Bock, D., Burnett, A.L.: "Combination of Vacuum Erection Device and PDE5 Inhibitors as Salvage Therapy in PDE5 Inhibitor Nonresponders with Erectile Dysfunction." J. Sex. Med. 6 (2009), 2561-2567.
  165. Magheli, A., Burnett, A.L.: "Erectile Dysfunction following Prostatectomy: Prevention and Treatment." Nat. Rev. Urol. 6 (2009), 415-427.
  166. Walz, J., Burnett, A.L., Costello, A.J., Eastham, J.A., Graefen, M., Guillonneau, B., Menon, M., Montorsi, F., Myers, R.P., Rocco, B., Villers, A.: "A Critical Analysis of the Current Knowledge of Surgical Anatomy Related to Optimization of Cancer Control and Preservation of Continence and Erection in Candidates for Radical Prostatectomy." Eur. Urol. 57 (2010), 179-192.
  167. Musicki, B., Liu, T., Strong, T.D., Lagoda, G.A., Bivalacqua, T.J., Burnett, A.L.: "Post-translational Regulation of Endothelial Nitric Oxide Synthase (eNOS) by Estrogens in the Rat Vagina." J. Sex. Med. 7 (2010), 1768-1777.
  168. Bivalacqua, T.J., Ross, A.E., Strong, T.D., Gebska, M.A., Musicki, B., Champion, H.C., Burnett, A.L.: "Attenuated Rho-A/Rho-kinase Signaling in Penis of Transgenic Sickle Cell Mice." Urology 76 (2010), 510, e7-12.
  169. Musicki, B., Liu, T., Lagoda, G.A., Strong, T.D., Sezen, S.F., Johnson, J.M., Burnett, A.L.: "Hypercholesterolemia-Induced Erectile Dysfunction: Endothelial Nitric Oxide Synthase (eNOS) Upcoupling in the Mouse Penis by NAD(P)H Oxidase." J. Sex. Med. 7 (2010), 3023-3032.
  170. Gratzke, C., Strong, T.D., Gebska, M.A., Champion, H.C., Stief, C.G. Burnett, A.L., Bivalacqua, T.J.: "Activated RhoA/Rho Kinase Impairs Erectile Function After Cavernous Nerve Injury in Rats." J. Urol. 184 (2010), 2197-2204.
  171. Facio, F., Kashiwabuschi, R., Nishi, Y., Leao, R., McDonnell, P., Burnett, A.L.: "Benign Prostatic Hyperplasia. Clinical Treatment Can Complicate Cataract Surgery." Int. Braz. J. Urol. 36 (2010), 563-570.
  172. Tozburun, S., Cilip, C.M., Lagoda, G.A., Burnett, A.L., Fried, N.M.: "Continuous-Wave Infrared Optical Nerve Stimulation for Potential Diagnostic Applications." J. Biomed. Opt. 15 (2010), 055012.
  173. Burnett, A.L., Goldstein, I., Andersson, K.E., Argiolas, A., Christ, G., Park, K., Xin, Z.C.: "Future Sexual Medicine Physiological Treatment Targets." J. Sex. Med. 7 (2010), 3269-3304.
  174. Montorsi, F., Adaikan, G., Becher, E., Giuliano, F., Khoury, S., Lue, T.F., Sharlip, I., Althof, S.E., Andersson, K.E., Brock, G., Broderick, G., Burnett, A.L., Buvat, J., Dean, J., Donatucci, C., Eardley, I., Fugl-Meyer, K.S., Goldstein, I., Hacket, G., Hatzichristou, D., Hellstrom, W., Incrocci, L., Jackson, G., Kadioglu, A., Levine, L., Lewis, R.W., Maggi, M., McCabe, M., McMahon, C.G., Montague, D., Montorsi, P., Mullhall, J., Pfaus, J., Porst, H., Ralph, D., Rosen, R., Rowland, D., Sadeghi-Nejad, H., Shabsigh, R., Stief, C., Vardi, Y., Wallen, K., Wasserman, M.: "Summary of the Recommendations on Sexual Dysfunctions in Men." J. Sex. Med. 7 (2010), 3572-3588.
  175. Rowland, D.L., Georgoff, V.L., Burnett, A.L.: "Psychoaffective Differences between Sexually Functional and Dysfunctional Men in Response to a Sexual Experience." J. Sex. Med. 8 (2011), 132-139.
  176. Musicki, B., Champion, H.C., Hsu, L.L., Bivalacqua, T.J., Burnett, A.L.: "Post-Translational Inactivation of Endothelial Nitric Oxide Synthase in the Transgenic Sickle Cell Mouse Penis." J. Sex. Med. 8 (2011), 419-426.
  177. Pierorazio, P.M., Bivalacqua, T.J., Burnett, A.L.: "Daily Phosphodiesterase Type-5 Inhibitor Therapy as Rescue for Recurrent Ischemic Priapism after Failed Androgen Ablation." J. Androl. 32 (2011), 371-374.
  178. Ferreira, J.M., Burnett, A.L., Rameau, G.A.: "Activity-Dependent Regulation of Surface Glucose Transporter-3." J. Neurosci. 31 (2011), 1991-1999.
  179. Johnson, J.M., Bivalacqua, T.J., Lagoda, G.A., Burnett, A.L., Musicki, B.: "eNOS-Uncoupling in Age-Related Erectile Dysfunction." Int. J. Impot. Res. 23 (2011), 43-48.
  180. Tajkarimi, K., Burnett, A.L.: "The Role of Genital Nerve Afferents in the Physiology of the Sexual Response and Pelvic Floor Function." J. Sex. Med. 8 (2011), 1299-1312.
  181. Schaeffer, A.J., Burnett, A.L.: "Non-Surgical Interventions for Peyronie‟s Disease: 2011 Update." J. Androl. 33 (2012), 3-14.
  182. Morrison, B.F., Burnett, A.L.: "Priapism in Hematological and Coagulative Disorders: An Update." Nat. Rev. Urol. 8 (2011), 223-230.
  183. Segal, R., Burnett, A.L.: "Erectile Preservation following Radical Prostatectomy." Ther. Adv. Urol. 3 (2011), 35-46.
  184. Burnett, A.L., Bivalacqua, T.J.: "Priapism: New Concepts in Medical and Surgical Management." Urol. Clin. North Am. 38 (2011), 185-194.
  185. Bivalacqua, T.J., Musicki, B., Kutlu, O., Burnett, A.L.: "New Insights into the Pathophysiology of Sickle Cell Disease-Associated Priapism." J. Sex. Med. 9 (2012), 79-87.
  186. Burnett, A.L.: "Sexual Health Outcomes Improvement in Sickle Cell Disease: A Matter of Health Policy?" J. Sex. Med. 9 (2012), 104-113.
  187. Tozburun, S., Lagoda, G.A., Burnett, A.L., Fried, N.M.: "Continuous-Wave Laser Stimulation of the Rat Prostate Cavernous Nerves using a Compact and Inexpensive All Single Mode Optical Fiber System." J. Endourol. 25 (2011), 1727-1731.
  188. Kutlu, O., Ross, A.E., Schaeffer, E.M., Gratzke, C., Stief, C.G., Strong, T.D., Burnett, A.L., Hedlund, P., Bivalacqua, T.J.: "Increased Expression of Nestin in the Major Pelvic Ganglion Following Cavernous Nerve Injury." Int. J. Impot. Res. 24(2012), 84-90.
  189. Lagoda, G.A., Xie, Y., Sezen, S.F., Hurt, K. J., Liu, L, Musicki, B., Burnett, A.L.: "FK506 Neuroprotection after Cavernous Nerve Injury Is Mediated by Thioredoxin and Glutathione Redox Systems." J. Sex. Med. 8 (2011) 3325-3334.
  190. Sezen, S.F., Lagoda, G.A., Burnett A.L.: "Neuronal Nitric Oxide Signaling Regulates Erection Recovery after Cavernous Nerve Injury." J. Urol. 187 (2012), 757-63.
  191. Burnett, A.L.: "Surgical Management of Ischemic Priapism." J. Sex. Med. 9 (2012), 114-20.
  192. Calenda, G., Strong, T.D., Pavlovich, C.P., Schaeffer, E.M., Burnett, A.L., Yu, W., Davies, K.P., Bivalacqua, T.J.: "Whole Genome Microarray of the Major Pelvic Ganglion after Cavernous Nerve Injury: New Insights into Molecular Profile Changes after Nerve Injury." BJU Int. 109 (2012), 1552-64.
  193. Segal R., Burnett A.L.: "Avanafil for the Treatment of Erectile Dysfunction." Drugs Today. 48 (2012), 7-15.
  194. Tozburun S., Lagoda G.A., Burnett A.L., Fried, N.M.: "Subsurface Near-Infrared Laser Stimulation of the Periprostatic Cavernous Nerves."J. Biophotonics. 5(2012), 793-800.
  195. Rowland, D.L., Lechner, K.H., Burnett, A.L.: "Factors Contributing to Psychoaffective Differences among Men with Sexual Dysfunction in Response to a Partnered Sexual Experience." J. Sex Marital Ther. (2012), 115-27.
  196. Burnett A.L., Sharlip I.D.: "Standard Operating Procedures for Priapism." J. Sex. Med. 10(2013), 180-94.
  197. Segal, R., Hannon, J.L., Lu, X., Kutlu, O., Burnett, A.L., Champion, H.C., Kim, J.H., Steppan, J., Berkowitz, D.E., Bivalacqua, T.J.: "Chronic Oral Administration of the Arginase Inhibitor 2 (S)-amino-6-boronohexanoic acid (ABH) Improves Erectile Function in Aged Rats." J. Androl. 33 (2012), 1169-75.
  198. Facio Jr., F.N., Burnett, A.L.: "Protective Effect of Annexin-A1 against Irreversible Damage to Cavernous Tissue after Cavernous Nerve Injury in the Rat." BJU Int. 110 (2012), 1346-51.
  199. Salonia, A., Burnett, A.L., Graefen, M., Hatzimouratidis, K., Montorsi, F., Mulhall, J.P., Stief, C.: "Prevention and Management of Postprostatectomy Sexual Dysfunctions. Part 1: Choosing the Right Patient at the Right Time for the Right Surgery." Eur Urol. 62 (2012) 261-72.
  200. Salonia, A., Burnett, A.L., Graefen, M., Hatzimouratidis, K., Montorsi, F., Mulhall, J.P., Stief, C.: "Prevention and Management of Postprostatectomy Sexual Dysfunctions. Part 2: Recovery and Preservation of Erectile Function, Sexual Desire, and Orgasmic Function." Eur Urol. 62 (2012) 273-86.
  201. Musicki, B., Liu, T., Sezen, S.F., Burnett, A.L.: "Targeting NADPH Oxidase Decreases Oxidative Stress in the Transgenic Sickle Cell Mouse Penis." J. Sex Med. (2012) [Epub ahead of print].
  202. Morrison, B.F., Burnett, A.L.: "Stuttering Priapism: Insights into Pathogenesis and Management." Curr Urol Rep. 13 (2012) 268-76.
  203. Rowland, D.L., Myers, A.L., Adamski, B.A., Burnett, A.L.: Role of Attribution in Affective Responses to a Partnered Sexual Situation among Sexually Dysfunctional Men." BJU Int. 111(2013), E103-9.
  204. Wang, R. Burnett, A.L., Heller, W.H., Omori, K., Kotera, J., Kikkawa, K., Yee, S., Day, W.W., Didonato, K., Peterson, C.A.: "Selectivity of Avanafil, a PDE5 Inhibitor for the Treatment of Erectile Dysfunction: Implications for Clinical Safety and Improved Tolerability." J. Sex Med. 9(2012) 2122-9.
  205. Nehra, A., Jackson, G., Minor, M., Billups, K.L., Burnett, A.L., Buvat, J., Carson, C.C., Cunningham, G.R., Ganz, P., Goldstein, I., Guay, A.T., Hackett, G., Kloner, R.A., Kostis, P., Ramsey, M., Rosen, R., Sadovsky, R., Seftel, A.D., Shabsigh, R., Vlachopoulos, C., Wu, F.C.: "The Princeton III Consensus Recommendations for the Management of Erectile Dysfunction and Cardiovascular Disease." Mayo Clin Proc. 87 (2012), 766-78.
  206. Burnett, A.L., Hellstrom, W.J.: "Management of Erectile Dysfunction: Great Progress, Greater Promise." J. Androl. 33(2012), 1107-10.
  207. Cellek, S., Bivalacqua, T.J., Burnett, A.L., Chitaley, K., Lin, C.S.: "Common Pitfalls in Some of the Experimental Studies in Erectile Function and Dysfunction: A Consensus Article." J. Sex Med. 9 (2012), 2770-84.
  208. Lagoda, G., Sezen, S.F., Cabrini, M.R., Musicki, B., Burnett, A.L.: "Molecular Analysis of Erection Regulatory Factors in Sickle Cell Disease-Associated Priapism in Human Penis." J. Urol. 189(2013), 762-8.
  209. Hurt, K.J., Sezen, S.F., Lagoda, G.F., Musicki, B., Rameau, G.A., Snyder, S.H., Burnett, A.L.: "Cyclic AMP-Dependent Phosphorylation of Neuronal Nitric Oxide Synthase Mediates Penile Erection." Proc Natl Acad Sci USA. 109(2012), 16624-9.
  210. Segal, R.L., Readal, N., Pierorazio, P.M., Burnett, A.L., Bivalacqua, T.J.: "Corporal Burnett "Snake" Surgical Maneuver for the Treatment of Ischemic Priapism: Long-Term Follow-Up." J. Urol. 189(2013), 1025-9.
  211. Hannan, J.L., Albersen, M., Kutlu, O., Gratzke, D., Stief, C.G., Burnett, A.L., Lysiak, J.J., Hedlund, P., Bivalacqua, T.J.: "Inhibition of Rho-kinase Improves Erectile Function, Increases Nitric Oxide Signaling and Decreases Penile Apoptosis in a Rat Model of Cavernous Nerve Injury." J. Urol. 189(2013), 1155-61.
  212. Segal, R.L., Bivalacqua, T.J., Burnett, A.L.: "Irbesartan Promotes Erection Recovery After Nerve-Sparing Radical Retrobupic Prostatectomy: A Retrospective Long-Term Analysis." BJU Int. 10 (2012), 1782-6.
  213. Levine, L.A., Burnett, A.L.: "Standard Operating Procedures for Peyronies‟s Disease." J. Sex Med. 10 (2013), 230-44.
  214. Mulhall, J.P., Burnett, A.L., Wang, R., McVary, K.T., Moul , J.W., Bowden, C.H., Didonato, K., Shih, W., Day, W.W.: "A Phase 3, Placebo-Controlled Study of the Safety and Efficacy of Avanafil for the Treatment of Erectile Dysfunction Following Nerve-Sparing Radical Prostatectomy." J. Urol. 189(2012), 2229-36.
  215. Massanyi, E.Z., Gupta, A., Goel, S., Gearhart, J.P., Burnett, A.L., Bivalacqua, T.J., Redett, R.J.: "Radial Forearm Free Flap Phalloplasty for Penile Inadequacy in Exstrophy Patients." J. Urol. (2012) [Epub ahead of print].
  216. Olujohungbe, A., Burnett, A.L.: "How I Manage Priapism due to Sickle Cell Disease." Br. J. Haematol. 160(2013), 754-65.
  217. Nehra, A., Jackson, G., Miner, M., Billups, K.L., Burnett, A.L., Buvat, J., Carson, C.C., Cunningham, G.R., Goldstein, I., Guay, A.T., Hackett, G., Kloner, R.A., Kostis, J., Montorsi, P., Ramsey, M., Rosen, R.C., Sadovsky, R., Seftel, A.,D., Vlachopoulos, C., Wu, F.C.: "Diagnosis and Treatment of Erectile Dysfunction for Reduction of Cardiovascular Risk." J. Urol. 189(2013), 2031-8.
  218. Porst, H., Burnett, A.L., Brock, G., Ghanem, H., Giuliano, F., Glina, S., Hellstrom, W., Martin-Morales, A., Salonia, A., Sharlip, I., The ISSM Standards Committee for Sexual Medicine: "SOP Conservative (Medical and Mechanical) Treatment of Erectile Dysfunction." J. Sex Med. 10(2013), 130-171.
  219. Burnett, A.L., Kan-Dobrosky, N., Miller, M.G.: "Testosterone Replacement with 1% Testosterone Gel and Priapism: No Definite Risk Relationship". J. Sex Med. 10(2013), 1151-61.
  220. Chaux A., Cubilla A.L., Haffner M.C., Lecksell K.L., Sharma R., Burnett A.L., Netto G.J.: "Combining Routine Morphology, p16INK4a Immunohistochemistry, and in situ Hybridization for the Detection of Human Papillomavirus Infection in Penile Carcinomas: A Tissue Microarray Study Using Classifier Performance Analyses." Urol Oncol. (2013) [Epub ahead of print].
  221. Chung J.Y., Chen H., Midzak A., Burnett A.L., Papadoulos V., Zirkin B.R.: "Drug Ligand-Induced Activation of Translocator Protein (TSPO) Stimulates Steroid Production by Aged Brown Norway Rat Leydig Cells." Endocrinology. 154 (2013), 2156-65.
  222. Burnett A.L.: "Current Rehabilitation Strategy: Clinical Evidence for Erection Recovery After Radical Prostatectomy." Transl Androl Urol. 2(2013), 24-31.
  223. Morrison B.F., Reid M., Madden W., Burnett A.L.: "Testosterone Replacement Therapy Does Not Promote Priapism in Hypogonadal Men with Sickle Cell Disease: 12-month Safety Report." Andrology, (2013) [Epub ahead of print].
  224. Segal, R.L., Burnett A.L.: "Surgical Management for Peyronie‟s Disease." World J. Mens Health. 31(2013), 1-11.
  225. Jackson, G., Nehra, A., Miner, M., Billups, K.L., Burnett, A.L., Buvat, J., Carson, C.C., Cunningham, G., Goldstein, I., Guay, A.T., Hackett, G., Kloner, R.A., Kostis, J.B., Montorsi, P., Ramsey, M., Rosen, R., Sadovsky, R., Seftel, A.D., Shabsigh, R., Vlachopoulos, C., Wu, F.C.: "The Assessment of Vascular Risk in Men with Erectile Dysfunction: The Role of the Cardiologist and General Physician." Int. J. Clin. Pract. 67(2013),1163-72.
  226. Segal, R.L., Cabrini, M.R., Harris, E.D., Mostwin, J.L., Bivalacqua, T.J., Burnett, A.L.: "Combined Inflatable Penile Prosthesis-Artificial Urinary Sphincter Implantation: No Increased Risk of Adverse Events Compared to Single or Staged Device Implantation." J. Urol. 190 (2013), 2183-8.
  227. Bivalacqua, T.J., Musicki, B., Hsu, L.L., Berkowitz, D.E., Champion, H.C., Burnett, A.L.: "Sildenafil Citrate-Restored eNOS and PDE5 Regulation in Sickle Cell Mouse Penis Prevents Priapism Via Control of Oxidative/Nitrosative Stress." PLoS One. 8(2013),e68028.
  228. Chaux, A., Munari, E., Katz, B., Sharma, R., Lecksell, K., Cubilla, A.L., Burnett, A.L., Netto, G.J.: "The Epidermal Growth Factor Receptor is Frequently Overexpressed in Penile Squamous Cell Carcinomas: A Tissue Microarray and Digital Image Analysis Study of 112 Cases." Hum. Pathol. 44(2013) 2690-5.
  229. Segal, R., Tajkarimi, K., Burnett, A.L.: "Viberect® Penile Vibratory Stimulation System: Evaluation of Its Erectogenic Efficacy." Can. J. Urol. 20 (2013) 6844-7.
  230. Cabrini, M.R., Sezen, S.F., Lagoda, G., Segal, R.L., Feng, Z., Andreoni, C., Burnett, A.L.: "Fibrotic Protein Expression Profiles in Penile Tissue of Patients with Erectile Dysfunction." Urology. 82(2013), 975.e1-6.
  231. Darouiche, R.O., Bella, A.J., Boone, T.B., Brock, G., Broderick G.A., Burnett, A.L., Carrion R., Carson C. 3rd, Christine, B., Dhabuwala, C.B., Hakim, L.S., Henry, G., Jones, L.A., Khera, M., Montague, D.K., Nehra, A.: "North American Consensus Document on Infection of Penile Prostheses." Urology. 82(2013), 937-42.
  232. Tozburun, S., Hutchens, T.C., McClain, M.A., Lagoda, G.A., Burnett, A.L., Fried, N.M.: "Temperature-Controlled Optical Stimulation of the Rat Prostate Cavernous Nerves." J. Biomed Opt. 18(2013), 067001.
  233. Tozburun, S., Stahl, C.D., Hutchens, T.C., Lagoda, G.A., Burnett, A.L., Fried, N.M.: "ContinuousWave Infrared Subsurface Optical Stimulation of the Rat Prostate Cavernous Nerves Using a 1490-nm Diode Laser." Urology. 82(2013), 969-73.
  234. Lagoda, G., Sezen, S.F., Hurt, K.J., Cabrini, M.R., Mohanty, D.K., Burnett, A.L.: "Sustained Nitric Oxide (NO)-Releasing Compound Reverses Dysregulated NO Signal Transduction in Priapism." FASEB J 28 (2014), 76-84.
  235. Segal, R.L., Bivalacqua, T.J., Burnett, A.L.: "Current Penile-Rehabilitation Strategies: Clinical Evidence." Arab J. Urol. 11(2013), 230-236.
  236. Chaux, A., Han, J.S., Lee, S., Gonzalez-Roibon, N., Sharma, R., Burnett, A.L., Cubilla, A.L., Netto, G.J.: "Immunohistochemical Profile of the Penile Urethra and Differential Expression of GATA3 in Urothelial Versus Squamous Cell Carcinoma of the Penile Urethra." Hum Pathol. 44(2013), 2760-7. 19
  237. Goetz, T., Burnett, A.L.: "Prostate Cancer Risk after Anti-Androgen Treatment for Priapism." Int. Urol. Nephrol. 46(2014), 757-60.
  238. Musicki, B., Bivalacqua, T.J., Champion, H.C., Burnett, A.L.: "Sildenafil Promotes eNOS Activation and Inhibits NADPH Oxidase in the Sickle Cell Mouse Penis." J. Sex Med. 11(2014), 424-30.
  239. Chaux, A., Munari, E., Cubilla, A.L., Hicks, J., Lecksell, K., Burnett, A.L., Netto G.J.: "Immunohistochemical Expression of the Mammalian Target of Rapamycin Pathway in Penile Squamous Cell Carcinomas: A Tissue Microarray Study of 112 Cases." Histopathology 64 (2013), 863-71.
  240. Rowland, D.L., Adamski, B.A., Neal, C.J., Myers, A.L., Burnett, A.L.: "Self-Efficacy as a Relevant Construct in Understanding Sexual Response and Dysfunction." Sex Marital Ther. 41(2015), 60-71.
  241. Miner, M., Nehra, A., Jackson, G., Bhasin, S., Billups, K., Burnett, A.L., Buvat, J., Carson, C., Cunningham, G., Ganz, P., Goldstein, I., Guay, A., Hackett, G., Kloner, R.A., Kostis, J.B., Laflamme, K.E., Montorsi, P., Ramsey, M., Rosen, R., Sadovsky, R., Seftel, A., Shabsigh, R., Vlachopoulos , C., Wu, F.: "All Men with Vasculogenic Erectile Dysfunction Require a Cardiovascular Workup." Am J Med. 127 (2014), 174-82.
  242. Meldrum, D.R., Burnett, A.L., Dorey, G., Esposito, K., Ignarro, L.J: "Erectile Hydraulics: Maximizing Inflow While Minimizing Outflow." J Sex Med. 11 (2014), 1208-20.
  243. Hannan, J.L., Kutlu, O., Stopak, B.L., Liu, X., Castiglione, F., Hedlund, P., Burnett, A.L., Bivalacqua, T.J.: "Valproic Acid Prevents Penile Fibrosis and Erectile Dysfunction in Cavernous Nerve-Injured Rats." J Sex Med 11 (2014), 1442-51 .
  244. Segal, R.L., Cabrini, M.R., Bivalacqua, T. J., Burnett, A.L.: "Penile Straightening Maneuvers Employed During Penile Prosthesis Surgery: Technical Options and Outcomes." Int J Impot Res. 26 (2014), 182-5.
  245. Burnett, A.L., Anele, U.A., Trueheart, I.N., Strouse, J.J. Casella, J.F.: "Randomized Controlled Trial of Sildenafil for Preventing Recurrent Ischemic Priapism in Sickle Cell Disease." Am J Med.127 (2014), 664-8.
  246. Anele, U.A., Kyle Mack, A., Resar, L.M., Burnett, A.L.: "Hydroxyurea Therapy for Priapism Prevention and Erectile Function Recovery in Sickle Cell Disease: A Case Report and Review of the Literature." Int Urol Nephrol. 46 (2014), 1733-6.
  247. Segal, R.L., Camper, S.B., Burnett, A.L.: "Modern Utilization of Penile Prosthesis Surgery: A National Claim Registry Analysis." Int J Impot Res. 26 (2014), 167-71.
  248. Le, B., Chen, H., Zirkin, B., Burnett, A.L.: "New Targets for Increasing Endogenous Testosterone Production: Clinical Implications and Review of the Literature." Andrology 2 (2014), 484-90.
  249. Sezen, S.F., Lagoda, G., Musicki, B., Burnett, A.L.: "Hydroxyl Fasudil, an Inhibitor of Rho Signaling, Improves Erectile Function in Diabetic Rats: A Role for Neuronal ROCK." J Sex Med. 11 (2014), 2164-71.
  250. Segal, R.L., Camper, S.B., Ma, L., Burnett, A.L.: "Prediction Model for Penile Prosthesis Implantation for Erectile Dysfunction Management." Curr Med Res Opin. 30 (2014), 2131-7. 20
  251. Segal, R.L., Massanyi, E.Z., Gupta, A.D., Gearhart, J.P., Redett, R.J., Bivalacqua, T.J., Burnett, A.L.: "Inflatable Penile Prosthesis Technique and Outcomes after Radial Forearm Free Flap Neophalloplasty." Int J Impot Res. 27(2015), 49-53.
  252. Morrison, B.F., Anele, U.A., Reid, M.E., Madden, W.A., Feng, Z., Burnett, A.L.: "Is Testosterone Deficiency a Possible Risk Factor for Priapism Associated with Sickle Cell Disease?" Int Urol Nephrol. 47(2015), 47-52.
  253. Anele, U.A., Morrison, B.F., Burnett, A.L.: "Molecular Pathophysiology of Priapism: Emerging Targets." Curr Drug Targets 16(2014), 474-83.
  254. Anele, U.A., Burnett, A.L.: "Suprapubic Cystostomy for the Management of Urethral Injuries during Penile Prosthesis Implantation." Sex Med. 2 (2014), 178-81.
  255. Anele, U.A., Segal, R.L., Le, B.V., Burnett, A.L.: "External Validation of a Model for Penile Prosthesis Implantation for Erectile Dysfunction Management." Can J Urol. 6(2014), 7554-9.
  256. Bezerra, S.M. Chaux, A, Ball, M.W., Faraj, S.F., Munari, E., Gonzales-Roibon, N., Sharma, R., Bivalacqua, T.J., Burnett, A.L.: "Human Papillomavirus Infection and Immunohistochemical p16INK4a Expression as Predictors of Outcome in Penile Squamous Cell Carcinomas." Hum Pathol. 46 (2014), 532-40.
  257. Anele, U.A., Burnett, A.L.: "Erectile Dysfunction after Sickle Cell Disease-Associated Recurrent Ischemic Priapism: Profile and Risk Factors." J Sex Med. 12(2015), 713-9.
  258. Hannan, J.L., Albersen, M., Stopak, B.L., Liu ,X., Burnett, A.L., Hoke, A., Bivalacqua, T.J.: "Temporal Changes in Neurotrophic Factors and Neurite Outgrowth in the Major Pelvic Ganglion following Cavernous Nerve Injury. J Neurosci Res. 93(2015), 954-63.
  259. Burnett, A.L., Sezen, S.F., Hoke, A., Caggiano, A.O., Iaci, J., Lagoda, G, Musicki, B., Bella, A.J.: "GGF2 Is Neuroprotective in a Rat Model of Cavernous Nerve Injury-Induced Erectile Dysfunction." J Sex Med. 12 (2015), 897-905.
  260. Lipshultz, L.I., Goldstein, I., Seftel, A.D., Kaufman, G.J., Smith, T.M., Tursi, J.P., Burnett, A.L.: Clinical Efficacy of Collagenase Clostridium Histoloyticum in the Treatment of Peyronie's Disease by Subgroups: Results from Two Large, Double-Blind, Randomized, Placebo-Controlled, Phase 3 Studies. BJU Int. 116(2015), 650-6.
  261. Le, B., Burnett, A.L.: "Evolution of Penile Prosthetic Devices." Korean J Urol. 56(2015), 179-86.
  262. Anele, U.A., Le, B.V., Resar, L.M., Burnett, A.L.: "How I Treat Priapism." Blood. 125(2015), 35518.
  263. Burnett, A.L., Anele, U.A., Derogatis, LR.: "Priapism Impact Profile Questionnaire: Development and Initial Validation." Urology 85(2015), 1376-81.
  264. Anele, U.A., Morrison. B.F., Reid, M.E., Madden, W., Foster, S. Burnett, A.L.: "Overactive Bladder in Adults with Sickle Cell Disease." Neurourol Urodyn. (2015) [Epub ahead of print].
  265. Musicki, B., Zhang, Y., Chen, H., Brown, T.R., Zirkin, B.R., Burnett, A.L.: "Mechanism of Testosterone Deficiency in the Transgenic Sickle Cell Mouse." PLoS One. 10(2015), e0128694. 21
  266. Nehra,A., Alterowitz, R., Culkin, D.J., Faraday, M.M., Hakim, L.S., Heidelbaugh, J.J., Khera, M., Kirby, E., McVary, K.T., Miner, M.M., Nelson, C.J., Sadeghi-Nejad, H., Seftel, A.D., Shindel, A.W., Burnett, A.L.: "Peyronie's Disease: AUA Guideline". J Urol. 194(2015), 745-53.
  267. Dean, J.D., McMahon, C.G., Guay, A.T., Morgentaler, A., Althof, S.E., Becher, E.F., Bivalacqua, T.J., Burnett, A.L., Buvat, J., El Meliegy, A., Hellstrom, W.J., Jannini, E.A., Maggi, M., McCullogh, A., Torres, L.O., Zitzmann, M.: "The International Society of Sexual Medicine's Process of Care for the Assessment and Management of Testosterone Deficiency in Adult Men ." J Sex Med. 12(2015), 166086.
  268. Burnett, A.L: "Racial Disparities in Sexual Dysfunction Outcomes after Prostate Cancer Treatment: Myth or Reality?" J. Rac Ethn Health Disp. 31(2016), 154-9.
  269. Egan, K.B., Burnett, A.L., McVary K.T., Ni X., Suh,. M., Wong, D.G., Rosen, R.C.: "The Cooccurring Syndrome-Coexisting Erectile Dysfunction and Benign Prostatic Hyperplasia and Their Clinical Correlates in Aging Men: Results From the National Health and Nutrition Examination Survey." Urology 86(2015), 570-80.
  270. Egan, K.B., Suh, M., Rosen R.C., Burnett, A.L., Ni, X., Wong D.G., McVary, K.T.: "Rural vs. Urban Disparities in Association with Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia in Ageing Men, NHANES 2001-2008." Int J Clin Pract. 69(2015), 1316-25.
  271. Fried, N.M., Burnett, A.L.: "Novel Methods for Mapping the Cavernous Nerves during Radical Prostatectomy." Nat Rev Urol 12(2015), 451-60.
  272. Sopko, N.A., Matsui, H., Hannan J.L., Berkowitz, D., Champion, H.C., Hsu, L.L. Musicki, B., Burnett, A.L., Bivalacqua, T.J.: "Subacute Hemolysis in Sickle Cell Mice Causes Priapism Secondary to NO Imbalance and PDE5 Dysregulation." J Sex Med. 12(2015), 1878-85.
  273. Hawksworth, D.J., Burnett, A.L.: "Pharmacotherapeutic Management of Erectile Dysfunction". Clin Pharmacol Ther. 98(2015), 602-10.
  274. Anele, U.A., Burnett, A.L.: "Nitrergic Mechanisms for Management of Recurrent Priapism." Sex Med Rev. 3(2015), 160-168.
  275. Boyle, P., Koechlin, A., Bota, M., d'Onofrio, A., Zaridze, D.G., Perrin, P., Fitzpatrick, J., Burnett, A.L., Boniol, M.: "Endogenous and Exogenous Testosterone and the Risk of Prostate Cancer and Increased Prostate Specific Antigen (PSA): A Meta-Analysis." BJU Int. (2016), [Epub ahead of print].
  276. Musicki, B., Bella, A.J., Bivalacqua, T.J., Davies, K.P., DiSanto, M.E., Gonzalez-Cadavid, N.F., Hannan, J.L., Kim, N.N., Podlasek, C.J., Wingard C.J., Burnett, A.L.: "Basic Science Evidence for the Link Between Erectile Dysfunction and Cardiometabolic Dysfunction." J Sex Med. (2015), [Epub ahead of print].
  277. Ball, M.W., Bezerra, S.M., Chaux, A., Faraj, S.F., Gonzalez-Roibon, N., Munri, E.,  Sharma, R., Bivalacqua, T.J., Netto, G.J., Burnett A.L.: “Overexpression of Insulin-like Growth Factor-1 Receptor Is Associated With Penile Cancer Progression.” Urology. (2016), [Epub ahead of print].
  278. Corona, G., Isidori, A.M., Aversa, A., Burnett, A.L., Maggi, M.: “Endocrinologic Control of Men's Sexual Desire and Arousal/Erection.” J Sex Med. 13(2016), 317-37.
  279. Sopko, N.A., Burnett, A.L.: “Erection Rehabilitation Following Prostatectomy - Current Strategies and Future Directions.” Nat Rev Urol. 13(2016), 216-25.
  280. Burnett A.L.: “Penile Preserving and Reconstructive Surgery in the Management of Penile Cancer.” Nat Rev Urol. (2016), [Epub ahead of print].
  281. Musicki, B., Lagoda, G., Goetz, T., La Favor, J.D., Burnett, A.L.: “Transnitrosylation: A Factor in Nitric Oxide-Mediated Penile Erection.” J Sex Med 13(2016), 808-14.
  282. Dupervil, B., Grosse, S., Burnett, A.L., Parker, C.: “Emergency Department Visits and Inpatient Admissions Associated with Priapism Among Males with Sickle Cell Disease in the United States, 2006-2010.” PLoS One 11(2016), e0153257
  283. Musicki, B., Hannan, J.L., Lagoda, G., Bivalacqua, T.J., Burnett, A.L.: “Mechanistic Link Between Erectile Dysfunction and Systemic Endothelial Dysfunction in Type 2 Diabetic Rats.” Andrology (2016), [Epub ahead of print].
  284. Khera, M., Broderick, G.A., Dobs, A.S., Faraday, M.M., Goldstein, I., Hakim, L.S., Hellstrom, W.J., Kacker, R., Köhler, T.S., Mills, J.N., Miner, M., Sadeghi-Nejad, H., Seftel, A.D., Sharlip, I.D., Winters, S.J.,  Burnett, A.L.: “Adult-Onset Hypogonadism.” Mayo Clin Proc (2016) [Epub ahead of print]
  285. Hannan, J.L., Matsui, H., Sopko, N.A., Liu, X. Weyne, E., Albersen, M., Watson, J.W., Hoke, A., Burnett, A.L., Bivalacqua, T.J.: “Caspase-3 Dependent Nitrergic Neuronal Apoptosis Following Cavernous Nerve Injury is Mediated via RhoA and ROCK Activation in Major Pelvic Ganglion.” Sci Rep. 6(2016), 29416.
  286. Sopoko, N.A., Matsui, H., Lough, D.M., Miller, D., Harris, K., Kates, M., Liu, X., Billups, K., Redett, R., Burnett, A.L., Brandacher, G., Bivalacqua, T.J.: “Ex Vivo Model of Human Penile Transplantation and Rejection: Implications for Erectile Tissue Physiology.” Eur Urol (2016) [Epub ahead of print]
  287. Podlasek, C.A., Mulhall, J., Davies, K., Wingard, C.J., Hannan, J.L., Bivalacqua, T.J., Musicki, B., Khera, M., González-Cadavid, N.F., Burnett, A.L. 2nd: “Translational Perspective on the Role of Testosterone in Sexual Function and Dysfunction.” J Sex Med 13(2016), 1183-93.
  288. La Favor, J.D., Burnett, A.L.: “A microdialysis method to measure in vivo hydrogen peroxide and superoxide in various rodent tissues.” Methods (2016) [Epub ahead of print].
  289. Steppan, J., Tran, H.T., Bead, V.R., Oh, Y.J., Sikka, G., Bivalacqua, T.J., Burnett, A.L., Berkowitz, D.E., Santhanam, L.: “Arginase Inhibition Reverses Endothelial Dysfunction, Pulmonary Hypertension, and Vascular Stiffness in Transgenic Sickle Cell Mice.” Anesth Analg 123(2016), 652-8.
  290. Silva, F.H., Karakus, S., Musicki, B., Matsui, H., Bivalacqua, T.J., Dos Santos, J.L., Costa, F.F., Burnett, A.L.: “Beneficial effect of the nitric oxide donor compound 3-(1,3-dioxoisoindolin-2-yl)benzyl nitrate on dysregulated phosphodiesterase 5, NADPH oxidase and nitrosative stress in the sickle cell mouse penis: implication for priapism treatment.” J Pharmacol Exp Ther (2016) [Epub ahead of print].
  291. Joice, G.A., Burnett, A.L.: “Nonsurgical Interventions for Peyronie’s Disease: Update as of 2016.” World J Mens Health (2016) [Epub Aug23].
  292. Cocks, M., Taheri, D., Ball, M.W., Bezerra, S.M>., Del Carmen Rodriguez, M., ., Bivalacqua, T.J., Sharma, R.B., Meeker, A., Chaux, A., Burnett, A.L., Netto, G.J.: “Immune Checkpoint Status in Penile Squamous Cell Carcinoma: A North American Cohort.”  Hum Pathol (2016) [Epub ahead of print].
  293. Boyle, P., Koechlin, A., Bota, M., d'Onofrio, A., Zaridze, D.G., Perrin, P., Fitzpatrick, J., Burnett, A.L., Boniol, M.: “Endogenous and Exogenous Testosterone and the Risk of Prostate Cancer and Increased Prostate-Specific Antigen (PSA) Level: A Meta-Analysis”. BJU Int (2016) [Epub Feb24].
  294. Sopko, N.A., Matsui, H., Lough, D.M., Miller, D., Harris, K., Kates, M., Liu, X., Billups, K., Redett, R., Burnett, A.L., Brandacher, G., Bivalacqua, T.J.: “Ex Vivo Model of Human Penile Transplantation and Rejection: Implications for Erectile Tissue Physiology. Eur Urol (2016) [Epub ahead of print].
  295. La Favor, J.D., Burnett, A.L.: “A Microdialysis Method to Measure In Vivo Hydrogen Peroxide and Superoxide in Various Rodent Tissues.” Methods (2016) [Epub Jul21].
  296. Matsui, H., Musicki, B., Sopko, N.A., Liu, X., Hurley, P.J., Burnett, A.L., Bivalacqua, T.J., Hannan, J.L.: “ Early-stage Type 2 Diabetes Mellitus Impairs Erectile Function and Neurite Outgrowth from the Major Pelvic Ganglion and Downregulates the Gene Expression of Neurotrophic Factors. Urology (2016) [Epub ahead of print].
  297. Biebel, M.G., Burnett, A.L., Sadeghi-Nejad, H.: “Male Sexual Function and Smoking.” Sex Med Reviews 4(2016), 366-375.
  298. Pineda, M., Burnett, A.L.: “Penile Prosthesis Infections- A Review of Risk Factors, Prevention, and Treatment.” Sex Med Reviews 4(2016), 389-398.

Books

  1. Burnett, A.L.Patients‟ Guide to Prostate Cancer: Johns Hopkins Medicine. Jones and Barlett Publishers: Sudbury, MA, 2010
  2. Burnett, A.L.II, Morris, N.S. Prostate Cancer Survivors Speak Their Minds: Advice on Options, Treatments, and Aftereffects. John Wiley & Son, Inc.: Hoboken, NJ, 2010

Book Chapters

  1. Berrettini, W.H., Bardakjian, J., Burnett, A.L., Nurnberger,J.I., Gershon,E.S.: "Beta- Adrenergic Receptor Function in Human Adult Skin Fibroblasts: A Study of Manic- Depressive Illness." In: Clark, S., (Ed.) Receptors, Antidepressants, and Depression. Ciba Foundation, Symposium No. 123, 1986.
  2. Mostwin, J.L., Burnett, A.L.: "Anatomic Aspects of Urinary Incontinence." In: O'Donnell, P.D., (Ed.) Urinary Incontinence. Mosby-Year Book, Inc: St. Louis, MO, 1996.
  3. Burnett, A.L.: "Neurophysiology of Erectile Function and Dysfunction." In: Hellstrom, W., (Ed.) Handbook of Sexual Dysfunction. Allen Press, Inc.: Lawrence, KS, 1999.
  4. Wesselmann, U., Burnett, A.L.: "Genitourinary Pain." In: Wall, P.D., Melzack, R. (Eds.) Textbook of Pain. 4th Edition. Churchill Livingstone: New York, NY, 1999.
  5. Burnett, A.L.: "Significance of the Nitric Oxide Cascade in Erectile Function." In: Melman, A. (Ed.) Treatment of Erectile Dysfunction: Clinical and Research Perspectives. Telesymposia Proceedings, Prous Science: Barcelona, Spain, 2000.
  6. Andersson, K.-E, Burnett, A.L., Chen, K.K., Christ, G. J., Rampin, O., Stief, C.: " Current Research and Future Therapies." In: Jardin, A., Wagner, G., Khoury, F., Giuliano, F., Padma-Nathan, H., Rosen, R. (Eds.) Erectile Dysfunction. Health Publication Ltd: Plymouth, United Kingdom, 2000.
  7. Burnett, A.L., Rodriguez, R., Jarrett, T.: "Male Anatomy and Physiology." In: Greenfield, L.J., Mulholland, M.W., Oldham, K.T., Zelenock, G.B., Lillemoe, K.D. (Eds.) Surgery: Scientific Principles and Practice, 3rd Edition. Lippincott-Raven Publishers: Philadelphia, PA, 2001.
  8. Burnett, A.L.: "Erectile Dysfunction Module." In: Goldman D.R., (Ed.) Physicians‟ Information and Education Resources (PIER). American College of Physicians - American Society of Internal Medicine: Philadelphia, PA, 2001.
  9. Burnett, A.L.: "Physiology of Erection and Pathophysiology of Erectile Dysfunction." In: Robaire, B., Chemes, H., Morales, C.R. (Eds.) Andrology in the 21st Century. Medimond Publishing Company, Inc.: Englewood, N.J., 2001.
  10. Burnett, A.L.: "New Advances in the Medical Management of Sexual Dysfunction." In: Robaire, B., Chemes, H., Morales, C.R. (Eds.) Andrology in the 21st Century. Medimond Publishing Company, Inc.: Englewood, N.J., 2001.
  11. Burnett, A.L.: "Smoking and Erectile Dysfunction." In: Samet, J. (Ed.) Active Smoking and Health: A Report of the Surgeon General. U.S. Department of Health and Human Services: Rockville, MD, 2004.
  12. Fagan, P.J., Burnett, A.L.Rogers, L., Schmidt, W.W. Jr.: "Sexual Disorders." In: Barker, L.R., Burton, J.R., Zieve, P.D., Fiebach, N., Kern, D.E., Thomas, P., Ziegelstein, R. (Eds.) Principles of Ambulatory Medicine, Sixth Edition. Lippincott, Williams, and Wilkins: Philadelphia, PA, 2001.
  13. Burnett, A.L., Chang, A.G., Sezen, S.F., Crone, J.K.: "Cholinergic Stimulation of Penile Erection in Mice." In: Robaire, B., Chemes, H., Morales, C.R. (Eds.) Andrology in the 21st Century. Medimond Publishing Company, Inc.: Englewood, N.J., 2001.
  14. Burnett, A.L.: "Epidemiology and Physiology of Erectile Dysfunction." In: Carson, C. C., Nehra, A. (Eds.) PDE-5 Inhibitors in the Treatment of Erectile Dysfunction. InforMEDical Communications, Inc.: Carlisle, MA, 2001.
  15. Wesselmann, U., Burnett, A.L.: "Genitourinary Pain." In: Melzack, R., Wall, P.D. (Eds.) Handbook of Pain Management. Churchill Livingstone: Edinburgh, Scotland, 2002.
  16. Burnett, A.L.: "Special Populations." In: Nehra, A. (Ed.) Treating Erectile Dysfunction: Advances in PDE-5 Inhibitors. InforMedical Communications, Inc.: Carlisle, MA, 2002.
  17. Burnett, A.L.: "Urinary Incontinence: Management Strategies and the Impact of Emerging Therapies." In: Burnett, A.L.(Ed.) Clinical and Cost-Effective Strategies in the Management of Urinary Incontinence. Managed Care Consultant, Vol. 2, No. 7, 2002.
  18. Burnett, A.L.: "Penile Anatomy." In: Teloken, C., Tannhauser, M., Teodosio Da Ros, C. (Eds.) Sexual Dysfunction. Livraria e Editora Revinter Ltda: Matriz, Brasil, 2003.
  19. Burnett, A.L.: "Pathophysiology of Erectile Dysfunction."In: Teloken, C., Tannhauser, M.,Teodosio Da Ros, C. (Eds.) Sexual Dysfunction. Livraria e Editora Revinter Ltda: Matriz, Brasil, 2003.
  20. Anderson, K.E., Argiolas, A., Burnett, A.L., Chen, K.K., Mills, T.M., Steers, W.D.: "Future Treatment Targets." In: Lue, T.F., Basson, R., Rosen, R., Giuliano, F., Khoury, S., Montorsi, F. (Eds.) Sexual Medicine: Sexual Dysfunctions in Men and Women. Health Publications Ltd: Plymouth, United Kingdom, 2004.
  21. Burnett, A.L.: "Urinary and Sexual Dysfunction in Multiple Sclerosis and Myelitis." In: Johnson, R.T.et al (Eds.) Current Therapy in Neurologic Disease. Elsevier Inc.: Philadelphia, PA, 2005.
  22. Chan, D.Y., Burnett, A.L., Rodriguez, R., Jarrett, T.W.: "Male Genitourinary Anatomy andPhysiology." In: Mulholland, M.W., Lillemoe, K.D., Doherty, G.M., Maier, R.V., Upchurch, G.R. Jr. (Eds.) Greenfield‟s Surgery: Scientific Principles and Practice, 4th Edition. Lippincott Williams &Wilkins: Philadelphia, PA, 2006.
  23. Derogatis, L.R., Burnett, A.L., Rogers, L.C., Schmidt, Jr. C.W., Fagan, P.J.: "Sexual Disorders: Diagnosis and Treatment." In: Fiebach, N.H., Kern, D.E., Thomas, P.A., Ziegelstein, R.C. (Eds.) Baker, Burton and Zieve‟s Principles of Ambulatory Medicine, 7th Edition. Lippincott Williams &Wilkins: Philadelphia, PA, 2007.
  24. Roehrborn, C.G., Uzzo, R.G., Burnett, A.L., Dougherty, J., Lavelle, J.P., Lofholm, P., Miner, M.M., Quallich, S.: "Benign Prostatic Hyperplasia: Applying the Guidelines to Clinical Practice." Supplement to The Clinical Advisor, Haymarket Media Inc.: Montvale, NJ, 2006.
  25. Burnett, A.L.: "Erectile Dysfunction: Science and Medicine." In: Rowland, D.L. (Ed.) Annual Review of Sex Research, Volume XVII. Stoyles Graphic Services, Mason City, IA, 2006.
  26. Burnett, A.L.: "Priapism." In: Wein, A.J., Kavoussi, L.R., Novick, A.C., Partin, A.W., Peters, C.A. (Eds.): Campbell-Walsh UROLOGY, 9th Edition. Saunders Elsevier: Philadelphia, PA , 2007.
  27. Burnett, A.: "Treatment Strategies for Erectile Dysfunction." In: Feneley, M., Payne, H. (Eds.) Therapeutic Strategies in Prostate Cancer. Clinical Publishing: Oxford, UK, 2007.
  28. Burnett, A.L.: "Nerve Regeneration: Grafts, Conduits, and Strategies." In: Montague, D.K., Angermeier, K.W., Gill, I.S., Ross, J.H. (Eds.) Textbook of Reconstructive Urologic Surgery. Informa Healthcare: London, UK 2007.
  29. Canguven, O., Burnett, A.L.: "Future of Therapy of Priapism." In: Abdel-Hamid, I.A. (Ed.) Advances in Sexual Medicine: Drug Discovery Issues. Research Signpost: Kerala, India, 2008.
  30. Burnett, A.L.II: "Neuromodulatory Drugs for the Radical Prostatectomy Patient." In: Mulhall, J.P. (Ed.) Sexual Function in the Prostate Cancer Patient, Current Clinical Urology Series. Humana Press, New York, NY, 2009.
  31. Musicki, B., Burnett, A.L.II: "Pathophysiology of Erectile Dysfunction: Molecular Basis." In: Carson, C.C. III, Kirby, R.S., Goldstein, I., Wyllie, M.G. (Eds.) Textbook of Erectile Dysfunction. Informa Healthcare: New York, NY, 2009.
  32. Burnett, A.L.II: "Environmental Erectile Dysfunction." In: Carson, C.C. III, Kirby, R.S., Goldstein, I., Wyllie, M.G. (Eds.) Textbook of Erectile Dysfunction. Informa Healthcare: New York, NY, 2009.
  33. Bivalacqua, T.J., Strong, T.D., Champion, H.C., Burnett, A.L.II: "Stem and Endothelial Progenitor Cells in Erectile Biology: Future Therapeutic Applications and Potential Biomarker for Erectile Dysfunction." In: Carson, C.C. III, Kirby, R.S., Goldstein, I., Wyllie, M.G. (Eds.) Textbook of Erectile Dysfunction. Informa Healthcare: New York, NY, 2009.
  34. Bivalacqua, T.J., Musicki, B., Champion, H.C., Burnett, A.L.II: "Phosphodiesterase Type 5 Inhibitor Therapy for Priapism." In: Carson, C.C. III, Kirby, R.S., Goldstein, I., Wyllie, M.G. (Eds.) Textbook of Erectile Dysfunction. Informa Healthcare: New York, NY, 2009.
  35. Canguven, O., Burnett, A.L.: "Priapism Monograph." British Medical Journal Publishing Group Ltd: London, 2009 (URL: https://online.epocrates.com).
  36. Bivalacqua, T.J., Burnett, A.L.: "Priapism." In: Graham, S., Keane, T. (Eds.) Glenn‟s Urologic Surgery 7e. Lippincott, Williams & Williams, Philadelphia, PA, 2009.
  37. Pierorazio, P.M., Burnett, A.L.: "How Do Erections Occur? How Common is Erectile Dysfunction, What is its Etiology, and How Do You Evaluate Men with this Problem?" In: Robaire, B., Chan, P. (Eds.) Handbook of Andrology. Allen Press, Inc.: Lawrence, KS, 2010.
  38. Boyle, K.E., Burnett, A.L.: "Sexual Function and Dysfunction in Men and Women." In: Legato, M.J. (Ed.) Principles of Gender-Specific Medicine. Academic Press/Elsevier: London, UK, 2010.
  39. Morrison, B.F., Burnett, A.L.: "Priapism: Medical and Surgical Therapy." In: McVary, K.T. (Ed.) Contemporary Treatment of Erectile Dysfunction. Springer Science: New York, NY, 2011.
  40. Bivalacqua, T.J., Levey, H.R., Burnett, A.L.: "Priapism." In: Mulhall, J.P. et al (Eds.) Cancer and Sexual Health, Current Clinical Urology. Springer Science: New York, NY, 2011.
  41. Burnett, A.L.: "Evaluation and Management of Erectile Dysfunction." In: Wein, A.J., Kavoussi, L.R., Novick, A.C., Partin, A.W., Peters, C.A. (Eds.) Campbell-Walsh Urology, 10th Edition. Sanders Elsevier: Philadelphia, PA, 2011.
  42. Musicki, B., Burnett, A.L.: "Role of Oxidative Stress in ED: Unraveling the Molecular Mechanism." In: Agarwal, A. et al (Eds.) Studies on Men‟s Health and Fertility, Oxidative Stress in Applied Basic Research and Clinical Practice. Springer Science: New York, NY, 2012.
  43. Bivalacqua, T.J., Burnett, A.L.: "Operations for Priapism." In: Smith, J.A. Jr., Howards, S.S., Preminger, G.M. (Eds.) Hinman‟s Atlas of Urologic Surgery. Elsevier Saunders: Philadelphia, PA, 2012.
  44. Rosenblum, J.L., Burnett, A.L.: "Microsurgical Penile Revascularization, Replantation, and Reconstruction." In: Sandlow J.I. (Ed.) Microsurgery for Fertility Specialists: A Practical Text. Springer Science: New York, NY, 2013.
  45. Morrison, B.F., Burnett, A.L.: "Urological Complications of Sickle Cell Disease (Lesson 29)." In: Carroll, P.R. et al (Eds.) AUA Update Series. AUA Education and Research, Inc.: Linthicum, MD 2012.
  46. Lally, E.V., Burnett, A.L., Bivalacqua, T.J.: “Erectile Dysfunction in Scleroderma.” In: Varga, J. et al (Eds.) Scleroderma: From Pathogenesis to Comprehensive Management. Springer Science: New York, NY, 2012.
  47. Burnett, A.L., Anusionwu, I.: “Surgery for Priapism.” In: Brandes, S.B., Morey, A.F. (Eds.) Advanced Male Urethral and Genital Reconstructive Surgery. Humana Press/Springer: New York, NY 2013.
  48. Rao, P.K., Burnett, A.L., “Development of the Male Reproductive System.” In: Kavoussi, P. et al (Eds.) Clinical Urologic Endocrinology. Springer-Verlag: London, UK, 2013.
  49. Sadeghi-Nejad, H., Burnett, A.L.: “Male Sexual Function.” In: Samet, J., Pechacek, T.F., Norman, L.A., Taylor, P.L., (Eds.) The Health Consequences of Smoking – 50 Years of Progress:  A Report of the Surgeon General.  U. S. Department of Health and Human Services:  Atlanta, GA, 2014.
  50. Segal, R.L., Burnett, A.L.: “Implantation Materials for the Male Genitalia.” In: Salgado, C.J., Redett, R. (Eds.) Aesthetic and Functional Surgery of the Genitalia. Nova Science Publishers: Hauppauge, NY, 2015.
  51. Burnett, A.L., Readal, N.: “Priapism.” In: Keane, T.E., Graham, S.D. Jr. (Eds.) Glenn’s Urologic Surgery, Eighth Edition. Wolters Kluwer: Philadelphia, PA, 2016.
  52. Anele, U.A, Burnett, A.L.: “Management of Priapism (Lesson 16). In: Carroll, P.R. et al (eds.) AUA Update Series. AUA Education and Research, Inc.: Linthicum, MD, 2016

Books (Editorships)

  1. Gomella, L.G. (Ed-In-Chief); Andriole, G.L., Burnett, A.L., Casale, A.J., Flanigan, R.C., Keane, T.E., Moul, J.W., Thomas, R. (Assoc. Eds.) The 5-Minute Urology Consult, Second Edition. Wolters Kluwer Health/Lippincott, Williams and Wilkins: Philadelphia, PA, 2010 26

Other Media (audiovisual presentation)

  1. Walsh, P.C., Burnett, A.L., Partin, A.W.: "Anatomical Radical Retropubic Prostatectomy: Evolution of the Surgical Technique." American Urological Association National Meeting. San Antonio, TX. May 15-20, 1993.

INSTITUTIONAL ADMINISTRATIVE APPOINTMENTS

  • Advisory Committee for the Office of Funded Programs, 2001-Present
  • Postbaccalaureate Committee, Johns Hopkins University School of Medicine, Baltimore, MD; 2001-Present
  • Medical School Council, Johns Hopkins University School of Medicine; 1999-2003
  • Young Investigators' Day Committee, Johns Hopkins University School of Medicine, Baltimore, MD; 1997-Present
  • Faculty Advisory Committee, Johns Hopkins University School of Medicine, Brady Urological Institute, 1996-Present
  • Search Committee, Director of Biomedical Engineering Department, 2006-2007
  • Clinical Practice Association Practice Management Committee, 2005-2009
  • Johns Hopkins Medicine International, Physician Relationship Initiative, 2005-Present
  • Search Committee, Director of Neuroscience Department, 2004-2005
  • School of Medicine Committee on Admissions, 2007-Present 

PROFESSIONAL SOCIETIES

  • American Association of Genitourinary Surgeons; 2015-Present; Member
  • Society of Basic Urologic Research; 2010-Present; Member; 2015-Present; Nominations Committee
  • The Society of University Urologists; 2006-Present; Member
  • Society of Urologic Prosthetic Surgeons; 2006-Present; Member
  • American Society for Peripheral Nerve; 2003-Present
  • International Society for the Study of Women’s Sexual Health; 2000-Present; Member
  • The American College of Surgeons; 1999-Present; Member
  • The Society of Genitourinary Reconstructive Surgeons; 1998-Present; Member
  • American Urogynecologic Society; 1998-Present; Member
  • Urodynamics Society; 1997-Present; Member
  • The Society of Black Academic Surgeons; 1997-Present; Member
  • International Society for Impotence Research; 1996-Present; Member
  • Monumental City Medical Society; 1994-Present; Member
  • National Medical Association; 1994-Present; Member
  • Sexual Medicine Society of North America; 1994-Present; Member
  • American Society of Andrology; 1994-Present; Member
  • Society of Government Service Urologists; 1991 -Present; Member
  • American Urological Association; 1990-Present; Member
  • American Medical Association; 1988-Present; Member
  • Medical and Chirurgical Faculty of the State of Maryland; 1985-Present; Member
  • National Association for the Advancement of Colored People, Baltimore Branch; 1984-Present; Member
  • Reserve Officers’ Association of the United States; 1984-Present; Member
  • Sigma XI Scientific Research Society; 1984-Present; Member

ADVISORY COMMITTEES

  1. Urology Times Editorial Council, Sexual Dysfunction Consultant; 2015- Present
  2. AUA Update Series Advisory Committee; 2013 – Present, Member
  3. AUA Research Council, Mid Atlantic Section; 2013-2016, Representative
  4. Male Topic Area Work Group, National Heart, Lung, and Blood Institute/NIH and Health Resources Services Administration Hemoglobinopathies Uniform Medical Language Ontology Project; 2013-2014, Member
  5. FDA Nonprescription Drugs Advisory Committee; 2012, Member
  6. Practice Guidelines Sexual Dysfunction Panel, American Urological Association, 2012-2015, Co-Chairperson
  7. American Urological Association Foundation Research Scholar Reviews, Research Grant Review Committee, 2011, 2012
  8. American Urological Association Male Circumcision Task Force; 2008- Present, Member
  9. AUA Research Council Strategic Workgroup; 2007, Member
  10. NIDDK Workshop on Advancing Urologic Science and Career Development; 2007, Member
  11. American Society of Andrology Examination Committee; 2006-Present, Member
  12. American Society of Andrology Ad Hoc Industry Symposium Committee; 2006-2009, Chairman
  13.   American Urological Association Prostate Cancer Guideline Update Panel; 2009, Member
  14. American Society of Andrology Diversity Committee; 2004 - 2009, Chairman
  15. External Examiner, Jamaican Board of Urology Examination Committee (West Indies University);
    2006, 2008, 2011, 2012
  16. Board of Directors, Sexual Medicine Society of North America; 2005-2007, Member
  17. American Urological Association Prostate Cancer Outcomes Working Group; 2004-2006, Member
  18. American Society of Andrology Executive Council; 2004-2007; Member
  19.  FDA Advisory Committee for Reproductive Health Drugs; 2003-2007, Member
  20. American Society of Andrology 2003 Program Committee; 2001-Present; 2003 Postgraduate Course
    Chairman
  21. American Board of Urology Examination Committee; 2001-2005; Member
  22. Urologic and Kidney Development and Genitourinary Diseases Study Section, NIH Center for Scientific Review; 2001-2002, Member; 2004-2007, Member/Chairperso
  23. Society for the Study of Impotence, Website Committee; 2000-2003; Member
  24. Mid-Atlantic Section of the American Urological Association, Inc.: Nominating Committee, 1999-2000, Member; Arrangements Committee, 2001-2002, Chairman; Board of Directors, 2004-2007, Member;  Membership Committee, 2007,  Member; President-Elect, 2014-2015; President, 2015-2016
  25. Johns Hopkins Men’s Health Advisory Board; 1998-Present; Member
  26. National Kidney Foundation of Maryland Medical Advisory Board; 1997-Present; Member
  27. Johns Hopkins Comprehensive Women's Health Center Oversight Committee; 1997-Present; Member  
  28. Johns Hopkins Comprehensive Diabetes Center's Advisory Board; 1997-Present; Member

REVIEW GROUPS

  1. Special Emphasis Panel ZRG1 DKUS-G(90), Urological and Urogynecologic Applications including Small Business, NIH/NIDDK; February 20, 2015; Scientific Reviewer/Chairman
  2. Special Emphasis Panel ZDK1 GRB-7 (O2), George M. O’Brien Urology Cooperative Research Centers Program (U54), NIH/NIDDK; July 14-15, 2014; Scientific Reviewer
  3. Special Emphasis Panel ZDK1 GRB-R M3 1 Multidisciplinary K12 Urological Research Career Development Program, NIH/NIDDK; April 4, 2013; Scientific Reviewer
  4. 2012 Prostate Cancer Research Program-Health  Disparities Award Review-1 Peer Review Panel, Department of Defense USAMRMC, CDMRP; October 14-16, 2012; Scientific Reviewer
  5. Center for Scientific Review Special Emphasis Panel/Scientific Review Group 2013/01 ZRG1 DKUS-L (03) M; September 17, 2012; NIH Grant Reviewer
  6. Kidney and Urologic Diseases Study Section, NIH Center for Scientific Review, 2011/05 ZRG1 DKUS-L (03) M; March 2, 2011; NIH Grant Reviewer
  7. Urologic & Kidney Development & Genitourinary Diseases Study Section, Digestive, Kidney and Urological Systems Integrated Review Group, Center for Scientific Review, UKGD; June 3, 2010; NIH Grant Reviewer/Chairman
  8. Challenge Grant Editorial Panel 18, NIH Center for Scientific Review, Initials-ZRG1 DKUS-A 58R; July 20-21, 2009; NIH Grant Reviewer
  9. Department of Veterans Affairs Fall 2007 Research Proposal Meeting; November 19, 2007; Ad Hoc Reviewer
  10.  Urologic & Kidney Development & Genitourinary Diseases Study Section, Renal and Urological Studies Integrated Review Group, Center for Scientific Review, UKGD; May 15-16, 2007; NIH Grant Reviewer/Chairman.
  11. Center for Scientific Review Special Emphasis Panel, NIH Center for Scientific Review, ZRG1 RUS-G (11); April 4, 2007; NIH Grant Reviewer.
  12. Urologic & Kidney Development & Genitourinary Diseases Study Section, Renal and Urological Studies Integrated Review Group, Center for Scientific Review, UKGD; February 13-14, 2007; NIH Grant Reviewer/Chairman
  13. Urologic & Kidney Development & Genitourinary Diseases Study Section, Renal and Urological Studies Integrated Review Group, Center for Scientific Review, UKGD; October 4-5, 2006; NIH Grant Reviewer/Chairman
  14. Center for Scientific Review Special Emphasis Panel, NIH Center for Scientific Review, ZRG1 RUS-E (12); June 27, 2006; NIH Grant Reviewer
  15. Urologic & Kidney Development & Genitourinary Diseases Study Section, Renal and Urological Studies Integrated Review Group, Center for Scientific Review. UKGD; October 3-4, 2005; NIH Grant Reviewer/Chairman
  16. Center for Scientific Review Special Emphasis Panel, NIH Center for Scientific Review, ZRG1 RUS-E (111); February 29, 2006; NIH Grant Reviewer
  17. Urologic & Kidney Development & Genitourinary Diseases Study Section, Renal and Urological Studies Integrated Review Group, Center for Scientific Review, UKGD; February 27-28, 2006; NIH Grant Reviewer/Chairman
  18. Center for Scientific Review Special Emphasis Panel, NIH Center for Scientific Review, ZRG1 RUS-D (12); October 4, 2005; NIH Grant Reviewer
  19. Urologic & Kidney Development & Genitourinary Diseases Study Section, Renal and Urological
    Studies Integrated Review Group, Center for Scientific Review, UKGD; October 3-4, 2005; NIH Grant Reviewer/Chairman
  20. Center for Scientific Review Special Emphasis Panel, NIH Center for Scientific Review, 2005/10 Council ZRG1 RUS-D (12); June 28, 2005; NIH Grant Reviewer
  21. Center for Scientific Review Special Emphasis Panel, NIH Center for Scientific Review, 2005/10Council ZRG1 RUS-D (50); June 28, 2005; NIH Grant Reviewer/Chairman
  22. Urologic & Kidney Development & Genitourinary Diseases Study Section, NIH Center for Scientific Review, 2005/10 Council UKGD; June 27, 2005; NIH Grant Reviewer/Chairman
  23. Center for Scientific Review Special Emphasis Panel, NIH Center for Scientific Review, ZRG1 RUS-D (03); February 18, 2005; NIH Grant Reviewer
  24. Urologic & Kidney Development & Genitourinary Diseases Study Section, NIH Center for Scientific Review, UKGD;February 17-18, 2005; NIH Grant Reviewer/Chairman
  25. Center for Scientific Review Special Emphasis Panel, NIH Center for Scientific Review, ZRG1 RUS-D (12); October 12, 2004; NIH Grant Reviewer
  26. Urologic & Kidney Development & Genitourinary Diseases Study Section, NIH Center for Scientific Review, UKGD;October 11, 2004; NIH Grant Reviewer/Chairman
  27. Center for Scientific Review Special Emphasis Panel, NIH Center for Scientific Review, ZRG1 RUS-D (50); June 29, 2004; NIH Grant Reviewer/Chairman
  28.   Urologic & Kidney Development & Genitourinary Diseases Study Section, NIH Center for Scientific Review, UKGD; June 28-29, 2004; NIH Grant Reviewer
  29. Center for Scientific Review Special Emphasis Panel, NIH Center for Scientific Review, ZRG1 RUS-D (12); June 28, 2004; NIH Grant Reviewer
  30. Urologic & Kidney Development & Genitourinary Diseases Study Section, NIH Center for Scientific Review, Initials-ZRG1-UKGD (01) Q; March 15-16, 2004; NIH Grant Reviewer
  31. Musculoskeletal Oral and Skin Sciences 1RG, NIH Center for Scientific Review, Initials-SSS5 05M; December 15, 2003; NIH Grant Reviewer
  32. Clinical Sciences Special Emphasis Panel (Urology), NIH Center for Scientific Review, Initials-ZRG-UROL-01; July 9-10, 2002; NIH Grant Reviewer
  33.   Clinical Sciences Special Emphasis Panel (Urology), NIH Center for Scientific Review, Initials-NIH-CSR-UROL; March 12-13, 2002; NIH Grant Reviewer
  34. Clinical Sciences Special Emphasis Panel (Urology), NIH Center for Scientific Review, Initials-ZRG-UROL-01; November 8-9, 2001; NIH Grant Reviewer
  35. Clinical Sciences Special Emphasis Panel (Urology), NIH Center for Scientific Review, Initials-ZRG-UROL-01; July 16-17, 2001; NIH Grant Reviewer
  36. Clinical Sciences Special Emphasis Panel (Urology), NIH Center for Scientific Review, Initials-ZRG-UROL-01; March 6-7, 2001; NIH Grant Reviewer
  37. Clinical Sciences Special Emphasis Panel (Urology), NIH Center for Scientific Review,Initials-ZRG-UROL-01; November 14, 2000; NIH Grant Reviewer
  38. Clinical Sciences Special Emphasis Panel (Urology), NIH Center for Scientific Review,  Initials-ZRG-UROL-01/02; March 8-9, 2000; NIH Grant Reviewer
  39. Clinical Sciences Special Emphasis Panel (Urology), NIH Center for Scientific Review,Initials-ZRG1-UROL-01; March 15-16, 1999; NIH Grant Reviewer
  40. Clinical Sciences Special Emphasis Panel (Urology), NIH Center for Scientific Review, Initials-ZRG4-UROL-01; November 20,1997; NIH Grant Reviewer
  41. Clinical Sciences Special Emphasis Panel (Urology), NIH Division of Research Grants, Initials-ZRG4-GMB-05; March 18, 1997; NIH Grant Reviewer     
  42. Clinical Sciences Special Emphasis Panel (Urology), NIH Division of Research Grants, Initials-ZRG4-GMB-05, Group Code-NG8; November 19, 1996; NIH Grant Reviewer

CONSULTANTSHIPS

  1. International Consultation on Sexual Medicine 2015, 2014-2015; Committee Co-Chairman
  2.  Standards Committee for Sexual Medicine, International Society for Sexual Medicine; 2011-2012; Member
  3. Cardiometabolic Risks and Sexual Health, Princeton III Consensus Program; 2010-2011; Consultant
  4.  National Urologic Research Agenda, American Urological Association Foundation; 2010; Consultant
  5. Active Smoking and Health:  Surgeon General’s Report 2011, Office on Smoking and Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention; 2009-2011; Consultant
  6. Third International Consultation on Sexual Medicine, Future Treatment Targets for Sexual Dysfunction, International Consultation on Urological Diseases and International Society for Sexual Medicine; 2008-2009; Committee Chairman
  7. Second International Consultation on Erectile and Sexual Dysfunctions, Future Treatment Targets, International Consultation on Urological Diseases; 2003-2004; Consultant
  8.  Active Smoking and Health: Surgeon General’s Report 2001, Office on Smoking and Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention;  2000-4; Consultant
  9. Clinical Evidence, Physicians’ Information and Education Resource (PIER), American College of Physicians - American Society of Internal Medicine; 1999-2006; Consultant/Peer Reviewer
  10.    
  11. First International Consultation on Erectile Dysfunction, Current Research and Future Therapies, Palais des Congres and World Health Organization; 1998-1999; Consultant
  1. 2016 Distinguished Mentor Award, Urology Care Foundation, American Urological Association
  2. 2013 Martin Luther King Jr. Award for Community Service, Johns Hopkins University
  3. Faculty Teaching Award, Department of Urology, 2010
  4. Edward J. Stegman CPA Memorial Award (4.0 GPA); 2009; Johns Hopkins Carey Business School
  5. Alumni Member; 2009; Alpha Omega Alpha Honor Medical Society
  6. Certificate of Appreciation; 2008; American Society of Andrology
  7. First Place Award for Excellence; 2007; 27th Annual Jackson Hole Urology Conference
  8. Zorgniotti-Newman Prize, for Best Paper on Clinical Research in Sexual Medicine; 2006; 12th World
    Congress of the International Society for Sexual Medicine
  9. Jean Francois Ginestiẻ Prize, for Best Paper on Basic Science on Sexual Medicine (co-author); 2004;
    11th World Congress of the International Society for Sexual and Impotence Research
  10. Emil Tanagho Prize, for Best Innovative Research (co-author); 2002; 10th World Congress of the
    International Society for Sexual and Impotence Research
  11. Yamanouchi Best Abstract Prize in Impotence; 2001; American Urological Association
  12. Fellow; 1999; American College of Surgeons
  13. Pfizer Scholar in Urology Award; 1999; Pfizer, Inc.
  14. Yamanouchi Best Abstract Prize in Impotence; 1998; American Urological Association
  15. Merck Clinician Scientist Award; 1996; Merck & Co.
  16. First Place, Lapides Annual Essay Contest on Urodynamic and Neurourology Research; 1996; American Urological Association
  17. Searle New lnvestigator Research Award; 1994; AmericanFoundationfor Urologic Disease, Inc.
  18. Male Reproduction/Urology Prize Paper; 1993; American Fertility Society
  19. Second Place, Lapides Annual Essay Contest on Urodynamic and Neurourology Research; 1993; American Urological Association
  20. First Place, Laboratory Research, Annual Resident Prize Essay Contest; 1993; American Urological Association
  21. First Place, Basic Science, Resident Essay Competition; 1992; Mid-Atlantic Section of the American Urological Association
  22. Student Merit Award; 1992; American Society of Andrology
  23. Young Investigator Award for Post-Doctoral Investigation, Clinical Science; 1992; The Johns Hopkins University School of Medicine
  24. Summer Research Fellowship Program; 1985; Clinical Neurogenetics Branch, National Institute of Mental Health, National Institute of Health, Warren G. Magnuson Clinical Center
  25. Charles M. Cannon Memorial Prize; 1984; Biology Department Thesis Symposium, Princeton University
  26. Distinguished Military Graduate; 1984; Princeton University, R.O.T.C. Unit
  27. Order of Merit List; 1983; R.O.T.C. Advanced Camp, Fort Bragg, North Carolina
  28. Eagle Scout; 1976; Boy Scouts of America

    Title: “Treatments for Male Sexual Dysfunction."
    Patent No.: 5,439,938
    Date: August 8, 1995
    Inventors:Solomon H. Snyder, Arthur L. Burnett, Charles J. Lowenstein, David S. Bredt, Thomas S.K. Chang.
    Abstract: Methods and devices are taught for regulating penile erection and urethral function. Inhibitors of nitric oxide synthase and precursors of nitric oxide are applied to relax or contract the muscles of the corpus cavernosum and the urethra.

    Title: “Method for Treating Nerve Injury Caused as a Result of Surgery"
    Patent No.: Pending (Serial No. 10/156/735)
    Date: June 29, 2002
    Inventors: Joseph P. Steiner, Solomon H. Snyder, Arthur L. Burnett
    Abstract: Methods for treating nerve injury caused as a consequence of surgery, and specifically as a consequence of prostate surgery, or for methods of neuroprotection of penile innervation, by administering a neurotrophic compound to a patient in need thereof.

    Title: “Prevention and Treatment of Erectile Dysfunction”
    Patent No.:   Pending (JHU Ref. 4446)
    Date:  March 22, 2005
    Inventors:  Mohamad Allaf, Arthur L. Burnett
    Abstract:  Method for treating erectile dysfunction secondary to cardiovascular disease, neurological disease, post-surgical damage, diabetes, etc. using erythropoietin.

     

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved. Disclaimer
Email: webmaster@urology.jhu.edu | 600 North Wolfe Street, Baltimore, Maryland 21287

urology second opinion urology second opinion